Adjustable implant, system and methods

Abstract
Aspects of the disclosure relate to an adjustable implant configured to be implanted into a patient that includes an adjustable portion moveable relative to a housing. The adjustable implant may include various smart components for enhancing operation of the implant. Smart components may include a controller for managing operations and a transducer for communicating ultrasound data with an external interface device. Additional smart components may include a load cell within the housing for measuring an imparted load; a sensor for measuring angular position of the adjustable portion; a dual sensor arrangement for measuring imparted forces; a reed switch; a half piezo transducer; and an energy harvester.
Description
TECHNICAL FIELD

The subject matter described herein relates to an adjustable implant, an adjustable implant system and associated methods.


BACKGROUND

Distraction osteogenesis is a technique which has been used to grow new bone in patients with a variety of defects. For example, limb lengthening is a technique in which the length of a bone (for example a femur or tibia) may be increased. By creating a corticotomy, or osteotomy, in the bone, which is a cut through the bone, the two resulting sections of bone may be moved apart at a particular rate, such as one (1.0) mm per day, allowing new bone to regenerate between the two sections as they move apart. This technique of limb lengthening is used in cases where one limb is longer than the other, such as in a patient whose prior bone break did not heal correctly, or in a patient whose growth plate was diseased or damaged prior to maturity. In some patients, stature lengthening is desired, and is achieved by lengthening both femurs and/or both tibia to increase the patient's height.


Limb lengthening is often performed using external fixation, wherein an external distraction frame is attached to the two sections of bone by pins which pass through the skin. The pins can be sites for infection and are often painful for the patient, as the pin placement site remains a somewhat open wound “pin tract” throughout the treatment process. The external fixation frames are also bulky, making it difficult for patient to comfortably sit, sleep and move. Intramedullary lengthening devices also exist, such as those described in U.S. Patent Application Publication No. 2011/0060336, which is incorporated by reference herein.


SUMMARY

A first aspect of the disclosure relates to an adjustable implant configured to be implanted into a patient. The adjustable implant may include: an adjustable portion moveable relative to the housing; and a load cell within the housing for measuring a load imparted on the implant during movement of the adjustable portion relative to the housing or during movement of a bone relative to the housing.


A second aspect of the disclosure relates to a method. The method includes: adjusting an adjustable implant having: a housing; an adjustable portion moveable relative to the housing; and a load cell within the housing for measuring a load; and measuring, with the load cell, the load imparted on the implant during movement of the adjustable portion relative to the housing or during movement of a bone relative to the housing.


A third aspect of the disclosure relates to an adjustable implant. The adjustable implant includes: a housing; an adjustable portion movable relative to the housing; an actuator positioned within the housing and configured to cause movement of the adjustable portion relative to the housing; and a sensor positioned adjacent to the actuator and configured to monitor an angular position of the actuator.


A fourth aspect of the disclosure relates to a method. The method includes: adjusting an adjustable implant, the adjustable implant including: a housing; an adjustable portion moveable relative to the housing; an actuator positioned within the housing and configured to cause movement of the adjustable portion relative to the housing; and a sensor positioned adjacent to the actuator and configured to monitor an angular position of the actuator; sensing, via the sensor, an angular position of the actuator; and calculating a distraction length or a compression length of the adjustable implant based upon the number of rotations of the actuator.


A fifth aspect of the disclosure relates to an adjustable implant. The adjustable implant includes: a housing; an adjustable portion moveable relative to the housing; a first actuator configured to cause movement of the adjustable portion relative to the housing, the first actuator being actuated by an external adjustment device having a second actuator therein; a first sensor configured to measure a position of the first actuator; and a second sensor configured to measure a position of the second actuator within the external adjustment device.


A sixth aspect of the disclosure relates to a method. The method includes: adjusting an adjustable implant, the adjustable implant having a housing and an adjustable portion moveable relative to the housing; measuring a position of a first actuator of the adjustable implant, the first actuator being configured to cause movement of the adjustable portion relative to the housing; measuring a position of a second actuator of an external adjustment device, the external adjustment device configured to actuate the first actuator of the adjustable implant; and determining at least one of a distraction force, a distraction torque, a compression force, and a compression length based on the position of the first actuator and the position of the second actuator at a given time.


A seventh aspect of the disclosure relates to an adjustable implant. The adjustable implant includes: a housing; an adjustable portion moveable relative to the housing; a first actuator configured to cause movement of the adjustable portion relative to the housing, the first actuator being actuated by an external adjustment device having a second actuator therein; a first sensor located at a first position in the housing configured to measure a first magnetic field of the first actuator relative to the second actuator; a second sensor located at a second position in the housing configured to measure a second magnetic field of the first actuator relative to the second actuator; and a controller that determines at least one force by analyzing the first magnetic field and the second magnetic field.


An eighth aspect of the disclosure relates to a method. The method includes: adjusting an adjustable implant, the adjustable implant having a housing and an adjustable portion, the adjustable implant having a first actuator configured to cause movement of the adjustable portion relative to the housing in response to movement of a second actuator of an external adjustment device; using a first sensor positioned at a first location in the housing to measure a first magnetic field of the first actuator of the adjustable implant relative to the second actuator; using a second sensor positioned at a second location in the housing to measure a second magnetic field of the first actuator of the adjustable implant relative to the second actuator; and determining at least one force by analyzing the first magnetic field and the second magnetic field.


A ninth aspect of the disclosure relates to a signal transmission device. The signal transmission device includes: a housing; a half-cylinder piezoelectric transducer positioned within the housing and having an inner diameter and an outer diameter; a metal backing positioned adjacent the inner diameter; and a semiconductor package positioned within the housing and substantially surrounding the half-cylinder piezoelectric transducer and the metal backing.


A tenth aspect of the disclosure relates to an adjustable implant. The adjustable implant included: an implant housing; and a signal transmission device positioned within the implant housing, the signal transmission device including: a half-cylinder piezoelectric transducer having an inner diameter and an outer diameter; a metal backing positioned adjacent the inner diameter; and a semiconductor package positioned within the housing and substantially surrounding the half-cylinder piezoelectric transducer and the metal backing.


An eleventh aspect of the disclosure relates to an adjustable implant. The adjustable implant includes: a housing; an adjustable portion moveable relative to the housing upon application of a force supplied by an external adjustment device; a sensor disposed within the housing and configured to measure an angular position of an actuator positioned within the housing; a controller communicatively coupled to the sensor and configured to determine at least one of a distraction force and distraction length based on the angular position of the actuator; and a switch configured to activate at least one of the controller and sensor.


A twelfth aspect of the disclosure relates to a method. The method includes: providing an adjustable implant including: a housing and an adjustable portion moveable relative to the housing upon actuation of an actuator within the housing upon application of a force supplied by an external adjustment device; a sensor configured to sense an angular position of the actuator; and communicatively coupled to the sensor and configured to determine at least one of a distraction force and distraction length based on the angular position of the actuator; and activating at least one of the controller and the sensor when the external adjustment device is within a threshold proximity to the adjustable implant.


A thirteenth aspect of the disclosure relates to an implant configured to be implanted within a patient. The implant includes: a controller; an energy harvesting component configured to harvest energy imparted on the implant during movement of the patient having the implant therein; and an energy storage device configured to store the energy harvested by the energy harvesting component, wherein the energy harvested by the energy harvesting component provides power for the controller.


A fourteenth aspect of the disclosure relates to a method. The method includes: implanting an implant within a patient; harvesting energy from stresses imparted on the implant during movement by the patient having the implant implanted therein; and using the harvested energy to power at least one of a controller and a transducer of the implant.





BRIEF DESCRIPTION OF DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, show certain aspects of the subject matter disclosed herein and, together with the description, help explain some of the principles associated with the disclosed implementations. In the drawings,



FIG. 1 shows a side view of an adjustable implant according to embodiments of the disclosure;



FIG. 2 shows a cross-sectional view of an adjustable implant according to FIG. 1;



FIG. 3 shows an enlarged cross-sectional view of the actuating components of the adjustable implant at region A;



FIG. 4 shows an enlarged cross-sectional view of the adjustable implant at region B;



FIG. 5 shows a perspective view of the load cell of the adjustable implant according to embodiments of the disclosure;



FIG. 6 shows a perspective view of the magnet of the actuator of the implant;



FIG. 7 shows a schematic of the sensor, controller, transducer, and power supply components according to embodiments of the disclosure;



FIG. 8 shows an enlarged cross-sectional view of an alternative embodiment of the adjustable implant at region B without the load cell;



FIG. 9 shows a schematic of the first sensor, second sensor, controller, transducer, and power supply components according to embodiments of the disclosure;



FIG. 10 shows a phase shift diagram of the relationship of the magnet of the implant and the magnet of the external adjustment device;



FIG. 11 shows a schematic of a system used to determine the distraction force/torque by the adjustable implant of FIG. 8 according to one embodiment;



FIG. 12 shows schematics of various techniques for using dual sensors to analyze magnetic fields;



FIG. 13 shows a perspective view of a signal transmission device according to embodiments of the disclosure;



FIG. 14 shows a cross-sectional view of the signal transmission device within the housing of the implant according to embodiments of the disclosure;



FIG. 15 shows a schematic of an energy harvesting system according to embodiments of the disclosure;



FIG. 16 shows an illustrative external interface device;



FIG. 17 shows a front view of an external adjustment device according to embodiments of the disclosure;



FIG. 18 shows a cross-sectional side view the external adjustment device according to embodiments of the disclosure;



FIG. 19 shows a cross-sectional view of a magnet drive system including a motor having an internal motor speed sensor; and



FIG. 20 depicts an illustrative computing system according to embodiments of the disclosure.





It is noted that the drawings of the subject matter are not necessarily to scale. The drawings are intended to depict only typical aspects of the subject matter, and therefore, should not be considered as limiting the scope of the disclosed subject matter. In the drawings, like numbering represents like elements between the drawings.


DETAILED DESCRIPTION

The present disclosure describes various embodiments of an adjustable implant, an adjustable implant system and associated methods. The embodiments described herein can be used as an extramedullary limb lengthening device/system, intramedullary limb lengthening device/system, an adjustable spinal device/system. It is also contemplated that the embodiments described herein can be used in spinal fixation devices/systems, such as for example, in the treatment of scoliosis. More specifically, the present disclosure is directed to an adjustable implant having smart electronics that allows the adjustable implant to work more efficiently and intelligibly.


In certain embodiments, a system is provided for adjusting the position of two bone portions relative to each other that includes: (1) an adjustable implant 100 having various smart components (FIGS. 1-4) fixed within a patient, (2) an external adjustment device 400 (also referred to as an external remote control “ERC”) positioned external to the patient (FIGS. 17-19), and (3) an external interface device 305, e.g., a computer, a tablet, a smartphone, one or more Apps, etc., (FIG. 16) for interfacing with smart components in the adjustable implant 100. In alternative embodiments, some or all of the functions provided by external interface device 305 are integrated into external adjustment device 400.


I. General Implant Discussion



FIG. 1 shows a perspective view of the adjustable implant (i.e., distraction/compression device) 100. As shown, the adjustable implant 100 includes a housing 102 and an adjustable portion 104 moveable relative to the housing 102. The adjustable portion 104 may include a distraction rod configured to telescopically move relative to the housing 102. The housing 102 includes at least one fixation aperture 106 configured to receive a bone anchor therein for coupling the housing 102 to a first bone portion. The adjustable portion 104 includes at least one fixation aperture 108 configured to receive a bone anchor therein for coupling the adjustable portion 104 to a second bone portion. Thus, the second bone portion may also move relative to the first bone portion during movement of the adjustable portion 104 relative to the housing 102.


In order to grow or lengthen bone, the bone either has a pre-existing separation or is purposely cut or broken (e.g., via an osteotomy) to create this separation, dividing the bone into a first section and a second section. The cut may be done prior to implanting and securing the implant 100 or may be done after the implant 100 is implanted, for example by use of a flexible Gigli saw. As will be described herein, the adjustable portion 104 is configured to contract and/or retract relative to the housing 102. The implant 100 is configured to allow controlled, precise translation of the adjustable portion 104 relative to the housing 102 by non-invasive remote control, and thus controlled, precise translation of the bone segment that is secured to the adjustable portion 104 relative to the bone segment coupled to the housing 102.


Over the treatment period, the bone is regularly distracted, creating a new separation, into which osteogenesis can occur. Regularly distracted is meant to indicate that distraction occurs on a regular or periodic basis which may be on the order of every day or every few days. An exemplary distraction rate is one millimeter per day, although, other distraction rates may be employed. That is to say, a typical distraction regimen may include a daily increase in the length of the implant 100 by about one millimeter. This may be done, for example, by four lengthening periods per day, each having 0.25 mm of lengthening. The implant 100, as disclosed in more detail below, has a magnetic drive system, which allows the adjustable portion 104 to be telescopically extended from the housing 102, thus forcing the first section and the second section of the bone apart from one another. The implant 100 can also be regular compressed for controlled fusion of bone.



FIG. 2 depicts a cross-sectional view of the implant 100 shown in FIG. 1, which shows at one end, the housing 102 has an opening 118 for receiving the adjustable portion 104. FIG. 2 also highlights two sections A and B, which are depicted in greater detail in FIGS. 3 and 4 respectively. FIG. 3 generally depicts an enlarged cross-sectional view of the actuating components of the implant 100 and FIG. 4 depicts an enlarged cross-sectional view of various “smart components” of the implant 100.


As shown in FIG. 3, one or more o-rings 119 can be positioned about the adjustable portion 104 between the adjustable portion 104 and the housing 102. In some embodiments, a portion of the outer surface of the adjustable portion 104 and/or a portion of an internal surface of the housing 102 can be recessed to accommodate the o-ring(s) 119. The o-ring(s) 119 can help facilitate proper sealing between the housing 102 and the adjustable portion 104 so that bodily fluid does not enter the housing 102 when the implant 100 is implanted. The housing 102 is sealably closed at the other end by the attachment of an end cap 120. The end cap 120 may be attached to the housing 102 by means of welding, adhesive bonding, or other joining techniques. Further, an o-ring (not shown) may be provided between the end cap 120 and the housing 102 to help provide a seal. In use, the adjustable portion 104 is driven from the housing 102 by means of an actuator 121. The actuator may include a lead screw 122 and a cylindrical permanent magnet 123. The lead screw 122 turns inside a nut 126 that is secured to an inner surface adjacent to a cavity of the adjustable portion 104 in which the lead screw 122 is disposed. The nut 126 is positioned between the lead screw 122 and the adjustable portion 104. The lead screw 122 is mechanically coupled, in an indirect manner, to the cylindrical permanent magnet 123 contained within a magnet housing 124. As explained in more detail herein, rotation of the cylindrical permanent magnet 123, which is magnetically driven by an external adjustment device 400 (FIGS. 17-19), effectuates rotation of the lead screw 122. Rotation of the lead screw 122 then translates into axial movement of the adjustable portion 104 relative to the housing 102.


The cylindrical permanent magnet 123 is fixedly contained within a magnet casing 126 using, for example, an adhesive such as an epoxy. The magnet casing 126 rotates relative to the magnet housing 124. The cylindrical magnet 123 may be a rare earth magnet such as Nd—Fe—B and may be coated with Parylene or other protective coatings in addition to being protected within the magnet casing 126, for example hermetically potted with epoxy. The magnet casing 126 contains an axle 132 on one end which attaches to the interior of a radial bearing 134. This arrangement allows the cylindrical magnet 134 to rotate with minimal torsional resistance. A maintenance member 136 may be positioned in proximity to and/or adjacent to the cylindrical permanent magnet 123. The maintenance member 136 keeps the implant 100 from being accidentally adjusted by movements of the patient. The maintenance member 136 is positioned proximate and axially spaced from the magnet 123. The maintenance member 136 is made from a magnetically permeable material, such as 400 series stainless steel. The maintenance member 136 can, for example, be generally cylindrical in shape having two spaced apart tabs separated by gaps. When the implant 100 is not being adjusted (e.g., using an external adjustment device), the magnetic poles of the radially-poled cylindrical magnet are magnetically attracted to the tabs. However, when the magnet 123 is forced to rotate due to the effect of a sufficiently large rotating magnetic field, the magnet 123 overcomes the smaller attractions of the tabs. The maintenance member 136 also includes flanged extension and/or flanged extension fingers for engaging with the end cap 120 and/or housing 102. Additional details of the maintenance member can be found in U.S. Pat. Pub. 20190015138, filed Jul. 26, 2018, which is incorporated herein by reference as if set forth in its entirety. Other maintenance members such as those disclosed in U.S. Pat. No. 8,734,488 filed Aug. 4, 2011 and U.S. application Ser. No. 13/525,058 filed Jun. 15, 2012 can also be used, each of which are incorporated herein by reference as if set forth in its entirety.


At its other, opposing end, the magnet housing 126 includes an axle 142, which is attached to a first planetary gear set 144. The axle 142 includes the sun gear of the first planetary gear set 144, the sun gear turning the planetary gears of the first planetary gear set 144. The first planetary gear set 144 serves to reduce the rotational speed and increase the resultant torque delivery from the cylindrical magnet 123 to the lead screw 122. A second planetary gear set 146 and a third planetary gear set 148 are also shown between the first planetary gear set 144 and the lead screw 136, for further speed reduction and torque augmentation. The number of planetary gear sets and/or the number of teeth in the gears may be adjusted, in order to achieve the desired speed and torque delivery.


The planetary gear sets 144, 146, 148 output to a planetary gear output shaft 152. The planetary gear output shaft 152 extends through a thrust bearing 154 and is secured (by welding and the like) to a lead screw coupling cap 156. The lead screw 122 is secured to the lead screw coupling cap 156 by a locking pin 158, which extends through a hole in the lead screw 122 and holes in the lead screw coupling cap 156. A locking pin retainer 162 is a cylinder that surrounds the locking pin 158, holding this assembly together. Attaching the lead screw 122 to the rest of the magnet/gear assembly in this manner, assures that the design is not over-constrained, and thus that the lead screw 122 does not gall with the nut 126. In addition, a biocompatible grease and/or fluorinated oil, such as, for example Krytox® (Krytox is a registered trademark of E. I. DU PONT DE NEMOURS AND COMPANY), may be used on the moving parts (lead screw, nut, bearings, housing, and distraction shaft) in order to minimize frictional losses. The lead screw 122 is able to freely rotate within a cavity of the distraction shaft 104, and only need engage with the short length of the nut 126, this feature also minimizing frictional losses.


II. Smart Components


In certain embodiments, one or more smart components are described that enhance the operation of the implant 100. As shown in FIG. 4, the various smart components can be positioned within a chamber in the housing 102 that is separate from the actuating components (i.e., the actuator 121).


At the core of these enhancements is a controller 302 that provides, e.g., data processing and storage operations, and may be any type of controller known and used in the art including: high performance microcontrollers (MCUs), Programmable System on Chip (PSoC), Application Specific Integrated Circuit (ASIC) or any other type of controller or microcomputer. The controller 302 may be disposed on a printed circuit board which may also contain other electronic circuitry and connect other electrical components including: Analog to Digital Converter (ADC), Digital to Analog Converter (DAC), op-amps, memory, or any other electrical component. The controller 302 may further include a frequency synthesizer (i.e., creates carrier waves for the transceiver), power amplifiers, noise filters (i.e., conditions carrier wave), power and read strain gauges (i.e., force sensor controls), and may be configured to adjust carrier waves, power, etc., such as by computer executable instructions that interface with a user via a graphical user interface, as discussed below.


In addition, in certain embodiments, a transducer 304 coupled to the controller 302 provides a communication platform to exchange data with an external interface device 305 (FIG. 16) using, e.g., ultrasonic or ultrasound communications. In certain embodiments, the communication platform may include any device that induces sound waves or a mechanical vibration, and converts soundwaves to electronic signals, including for example: a piezoelectric transducer, a single crystal ultrasonic transducer, a lead zirconate titanate (PZT) ultrasonic transducer, piezoelectric polyvinylidene fluoride (PVDF) ultrasonic transducer, capacitive micromachined ultrasonic transducers (CMUT), piezoelectric micromachined ultrasonic transducers (PMUT), or any ultrasonic transducer known and used in the art. In some embodiments, the ultrasonic transducer may include one or more of: a thin film ultrasonic transducer, a flat ultrasonic transducer, a tubular ultrasonic transducer, a half-tubular ultrasonic transducer, etc. A benefit, for example, of a thin film ultrasonic transducer is the reduced thickness of the ultrasonic transducer. A benefit, for example, of a flat ultrasonic transducer is improved transmission and reception characteristics. A benefit, for example, of a tubular ultrasonic transducer is multi-directional (360° radial directional) transmission and reception. The type of ultrasonic transducer may be chosen to complement the application of the adjustable implant 100. In another embodiment, the transducer 304 can include a radiofrequency transducer. The transducer 304 is configured to receive instructions and data from the controller and configured to send such instructions and data to an external adjustment device 400 (FIGS. 17-19) and/or an external interface device 305, via, for example, ultrasound or radiofrequency waves. The transducer 304 is also configured to receive data and/or treatment instructions from the external interface device 305 or external adjustment device 400. It is understood that while various embodiments described herein utilize an ultrasonic device for a communication platform, any wireless device or technology could likewise be utilized, e.g., radio, Bluetooth, etc.


In order to power the smart components of the implant 100, one or more power supply components 310 may be used. The power supply components 310 include at least one battery energy storage device. For example, at least one lithium-ion battery or silver oxide battery could be used. However, any other now known or later developed medical grade energy storage device could be used without departing from aspects of the disclosure.


Further details of various smart components are provided below. It is understood that an implant may include one or more of the following components.


A. Load Cell


Referring to FIGS. 4 and 5, the load cell 306 is positioned within the housing 102 and is configured to measure a linear load, i.e., force, imparted on the adjustable implant 100. Illustrative types of loads that can be measured include “bone loading” and “elongation distraction.” Bone loading measures the amount of stress on the bone resulting from weight bearing activities, e.g., standing, walking, lifting, etc. Elongation distraction (or contraction) refers to the amount of stress imparted on the bone when the implant 100 is being adjusted, i.e., during movement of the adjustable portion 104 relative to the housing 102.


As shown in FIG. 4, both the housing 102 and load cell 306 include one or more apertures 106, 334, respectively, for receiving bone anchors therein (not shown). The apertures 334 of the load cell 306 have a smaller diameter than the apertures 106 within the housing 102 to allow the bone anchors to primarily anchor to the load cell 306, as opposed to the housing 102. This arrangement accordingly allows the load cell 306 to slide within the housing when a linear force is applied. The load may for example result from an adjustment of the implant (i.e., the adjustable portion 104 relative to the housing 102) or from a bone loading activity in which a force is applied to the load cell via bone anchors (e.g., bone relative to the housing 102). The linear motion of the load cell 306 then allows the load imparted on the bone or adjustable implant 100 to be detected by the load cell 306. In the example shown, the two apertures are shown angled within the implant 100. However, it is understood that other arrangements could be utilized, e.g., one, three or four perpendicular apertures, etc.


The load cell 306 includes at least one sensor, such as for example, a strain gauge. As shown in FIG. 5, the load cell 306 includes a substantially tubular body 308 having a first portion 312 with an outer diameter that is smaller than an outer diameter of the remaining portion 314 of the tubular body 308. In certain embodiments, the load cell comprises a force transducer that converts a force into an electrical signal. As the force applied to the load cell increases, the electrical signal changes proportionally, e.g., based on a change in electrical resistance. As shown, the first portion 312 of the load cell 306 includes a strain gauge having a first sensing element 316 and a second sensing element 318 that, e.g., are configured in a Wheatstone bridge arrangement to generate a voltage output that measures a displacement, e.g., in the range of 0-10 mm. Accordingly, as linear stress is imparted to the bone and/or implant 100, the load cell 306 can generate a voltage that is converted into a load value by the controller 302.


In some embodiments, the load cell 306 is coupled within the housing 102 via pin 320 (FIG. 4) extending through a pin hole 322 (FIG. 5) within the load cell 306 at a first end. However, other means for coupling the load cell 306 to the housing 102 can also be used without departing from aspects of the disclosure, such as for example a retainer member such as the one disclosed in U.S. 63/053,036 filed on Jul. 17, 2020, which is incorporated by reference as if set forth in its entirety.


Opposite the first end, the load cell 306 can be coupled to the controller 302 via wiring 324. In some embodiment, a protective housing (e.g., composed of a polymer such as polyether ether ketone (PEEK)) 326 can be positioned adjacent the load cell 306 within the housing 102. The protective housing 326 substantially surrounds the wiring 324 from the load cell 306 to the controller 302 within the housing 326 and protects the wiring 324 within housing 102.


As shown in FIG. 7, the controller 302 is configured to receive electrical signals from the load cell 306 via the wiring 324 and calculate load characteristics, e.g., a distraction force and/or distraction length. In addition, the arrangement can be configured to determine a compression force, and/or compression length based on the load measured by the load cell 306 when the implant 100 is used as a compression device. The controller 302 is configured to digitize the data obtained by the load cell 306, process the data and modulate the data into an ultrasound signal to be communicated by the transducer 304 to an external interface device 305 via a transceiver 307. The external interface device 305 and the transceiver 307 are each positioned external to the patient.


An illustrative method involving a load cell 306 includes implanting the implant 100 within a patient, such as for example within an intramedullary canal of a bone. An osteotomy is performed to create a first bone portion and a second bone portion. The housing 102 is coupled to the first bone portion and the adjustable portion 104 is coupled to the second bone portion. The method also includes adjusting the implant 100 having the housing 102, an adjustable portion/rod 104 moveable relative to the housing and a load cell 306 within the housing 102 for measuring a load imparted on the implant 100 during movement of the adjustable portion 104 relative to the housing 102. The method also includes measuring the load imparted on the implant 100 during movement of the adjustable portion 104 relative to the housing 102. More specifically, the measuring of the load includes using the load cell 306 to measure the load imparted on the bone anchors (not shown) positioned within the apertures 106 of the housing 102 and the apertures 334 of the load cell. The method can also include sending the measured load to an external interface device 305 via the transducer 304 and a transceiver 307. A medical professional can then view the measured load data from the external interface device 305 and use the measure load to determine additional data, such as for example, a distraction force, distraction torque and a distraction length or a compression force, compression torque and a compression length. The medical professional can then determine treatment instructions based on such data. The implant 100 and/or external adjustment device 400 can receive the treatment instructions and adjust the implant 100 based on the treatment instructions.


B. Actuator Position Sensing


Position sensing may be provided to determine a position of the actuator 121, e.g., how far it has been distracted or compressed, by measuring and tracking angular (i.e., rotational) movements of the actuator 121. To achieve this, a sensor 336 such as that shown in FIG. 4 can be utilized to monitor an angular position of the actuator 121 of the adjustable implant 100. More specifically, the sensor 336 is configured to monitor an angular position of the magnet 123 of the actuator 121 (FIG. 3), for example, by measuring at least one of a magnetic field strength, polarity, and dynamic direction. For example, as shown in FIG. 6 the sensor 336 monitors a position of the dipole moment or vector VPole representing the direction of the magnetic field of the magnet 123 of the actuator 121 as it rotates about the axis extending longitudinally through the magnet, Vaxis representing possible angles of 0°-360°.


In one embodiment, the sensor 336 can include a hall effect sensor, and more specifically, a unidirectional hall effect sensor, e.g., implemented on a printed circuit board. The sensor 336 can also include a rotary hall effect sensor, which can include, for example, a 4-hall element arrangement. The sensor 336 is positioned adjacent to and/or in proximity to the actuator 121. More specifically, the sensor 336 is positioned such that the sensor 336 can monitor the magnetic field emanating from the magnet 123 of the actuator 121 and collect angular position data. For example, in one embodiment, at each full rotation, sensor 336 can output a predefined signal. In other embodiments, sensor 336 can output a predefined signal at partial rotations, e.g., each quarter rotation as determined by a 4-hall element arrangement.


As shown in the illustrative system diagram of FIG. 7, the sensor 336 is communicatively coupled to the controller 302 (e.g., via wiring) and the controller 302 is configured to receive the angular position data of the actuator 121 from the sensor 336. In one embodiment, the controller 302 is configured to calculate and/or determine a distraction length or compression length of the adjustable implant 100 based on the number of rotations (or partial rotations) of the actuator 121. More specifically, the number of rotations of the actuator 121 can be correlated (e.g., with a look-up table) to a number of rotations of the lead screw 122 (FIG. 3) which is then used to determine the overall distraction length or compression length of the implant 100. In alternative embodiments, the collected rotation data can simply be digitized packaged for transmission to an external interface device 305, which can calculate a distraction or compression length.


In certain embodiment, the controller 302 is communicatively coupled to the transducer 304 (e.g., via wiring) and is configured to send data such as the number of rotations to external interface device 305 to be viewed by a medical professional and/or the patient. More specifically, a transceiver 307 positioned external the patient can be used to demodulate the signal transmitted by the transducer 304 into meaningful data digestible and interpretable by the external interface device 305. Once the signal is demodulated, the external transceiver 307 can send the demodulated data to the external interface device 305.


An illustrative method involving actuator position sensing includes implanting the implant 100 within a patient, such as for example within an intramedullary canal of a bone. An osteotomy is performed to create a first bone portion and a second bone portion. The housing 102 is coupled to the first bone portion and the adjustable portion 104 is coupled to the second bone portion. The method also includes adjusting the implant 100 having the housing 102, the adjustable portion/rod 104 moveable relative to the housing 102, an actuator 121 positioned within the housing 102 and configured to cause movement of the adjustable portion 104 relative to the housing 102; and a sensor 336 positioned adjacent to the actuator 121 and configured to monitor an angular position of the actuator 121 of the implant 100. The method also includes sensing, via the sensor 336, an angular position of the actuator 121, or more specifically, the magnet 123 of the actuator 121. The angular position of the magnet 123 can be used to determine a number of rotations of the magnet 123. The method also includes calculating a distraction length or compression length of the implant 100 based upon a number of rotations of the magnet 123/actuator 121. More specifically, the controller 302 positioned within the housing 102 and communicatively coupled to the sensor 336 is configured to determine the distraction length or the compression length of the implant 100. At least one of the distraction length, compression length or the number of rotations of the actuator 121 can be sent to an external interface device 305 via the transducer 304 which is also positioned within the housing 102 and the transceiver 307 positioned external to the patient. A medical professional can then view the determined distraction length and/or number of rotations of the actuator 121 via the external interface device 305. The medical professional can then determine treatment instructions based on such data. The implant 100 and/or external adjustment device 400 can receive the treatment instructions and adjust the implant 100 based on the treatment instructions.


C. Dual Magnet Load Sensors


1. Implant and External Magnet Sensing


In a further embodiment, in place of or in addition to using a load cell 306 to measure a compression/distraction force, a dual sensor arrangement as described in FIGS. 8-12 may be implemented to measure force loads associated with the adjustable implant 100. In the illustrative embodiment of FIG. 8, a first sensor 336 is included that is configured to measure a position and/or magnetic field information of the actuator 121 of the adjustable implant 100 (e.g., as described herein with reference to the actuator position sensing system) and a second sensor 346 is included in the implant 100 that is configured to measure a position and/or magnetic field information of the external actuator magnet 440 of the external adjustment device 400 (FIGS. 17-19). The moments of the two associated magnets are then evaluated with an algorithm to determine, e.g., a torque and/or compression/distraction force.


The first sensor 336 and second sensor 346 each include, for example, a printed circuit board having at least one sensor such as, for example, a hall effect sensor, configured to measure at least one of a magnetic field strength, polarity, and dynamic direction. In one example, the first sensor 336 includes a unidirectional hall effect sensor to read the position of the internal actuator magnet 123 and the second sensor 346 includes an omnidirectional hall effect sensor to read the position of the magnet of the external actuator 440 of the external adjustment device 400.


The first sensor 336 can be positioned adjacent to and/or in proximity to the actuator 121 and may comprise a multiple hall effect sensor configured to make differential strength measurements. In one embodiment, the first sensor 336 can include a rotary hall effect sensor (e.g., a four-hall effect sensor) and the second sensor 346 configure to measure magnetic strength in three axis. The second sensor 346 can be positioned at a location where the external magnet and internal magnet are least coupled, e.g., on an opposite side of the controller 302 from the first sensor 336 such that the controller 302 is positioned between the first 336 and second sensors 346. The controller 302 is configured to determine a position of the first actuator 336 and the second actuator 440 relative to each other at a given time based on data from obtained by the first and second sensors 336, 346. More particularly, the controller 302 is configured to monitor a position of the rotating magnet 123 (FIG. 3) of the actuator 121 and a position of the at least one rotating permanent magnet of the external actuator 440 in the external adjustment device 400.



FIG. 10 shows a phase shift diagram with line A representing the phase shift of the magnet of external actuator 440 of the external adjustment device 400 and line B representing the phase shift of the magnet 123 of the implant 100. As shown, the magnet 123 may lag behind the actuator 440 due at least in part to the torque put on the magnet 123 from the gear assembly (planetary gears 144, 146, 148) and the lead screw 122 interacting with the adjustable portion 104 such that a phase angle can be determined. By analyzing the lag/phase angle, coupling states, stalling states, force measurements, non-union states, consolidation states, etc., can be determined. For example, if line B lags too far behind line A, a stalling condition may have occurred.



FIG. 11 shows an illustrative schematic of how the distraction force or distraction torque, or the compression force or compression torque can be calculated. In one embodiment, the sensor 336 monitors the rotating magnetic field from the implant actuator 121 and provides an angular position of the magnet 123. The sensor 346 monitors the rotating magnetic field of the actuator 440 of the external adjustment device 400 and, e.g., provides the x, y, and z components, yaw, pitch and roll of the magnetic field. An algorithm 337 can be used to process the angular position of the rotating magnet 440 of the external adjustment device 400 and/or a distance of the rotating magnet 440 from the sensor 346 and determines one or more forces (e.g., a distraction force and distraction torque, and/or compression force and compression torque) based on the angular position of the implant magnet 123 and the angular position of the rotating magnet 440. In some embodiments, the algorithm 337 calculates one or more forces by applying one or more functions or lookup tables to readings from the sensors 336, 346. In some examples, readings from the sensors 336, 346 are provided as input to a machine learning algorithm trained on angular position and/or magnetic field data to output force information.



FIG. 9 depicts an associated system diagram in which the controller 302 captures and processes data from sensors 336, 346. Once processed, the transducer 304 is configured to send data associated with the first sensor 336 and the second sensor 346 to an external interface device 305 to be viewed by a medical professional and/or a patient. More specifically, an external transceiver 307 positioned external the patient can be used to demodulate the signal transmitted by the transducer 304 into meaningful data digestible and interpretable by the external interface device 305. Once the signal is demodulated, the transceiver 307 can send the demodulated data to the external interface device 305. Depending on the implementation, either controller 302 or an external system can implement algorithms to compute the force information from measurements captured by sensors 336, 346. In some examples, an algorithm calculates the distraction/compression force/torque by applying one or more functions or lookup tables to the measurements captured by the sensor 336, 346. In some embodiments, the measurements are provided as input to a machine learning algorithm trained on distraction force/torque data and the distraction force/torque is provided as output.


The top half of FIG. 12 describes the relationship between the implant magnet 123 and the external (ERC) magnet. As shown on the left, the external magnet and implant magnet are coupled. In the middle, when the ERC magnet tilts, the implant magnet follows immediately indicating the two are in phase with no torque. On the right, the implant magnet tilt lags behind the ERC magnet, indicating a counter torque.


An illustrative method involving a dual sensor arrangement includes implanting the implant 100 within a patient, such as for example within an intramedullary canal of a bone. An osteotomy is performed to create a first bone portion and a second bone portion. The housing 102 is coupled to the first bone portion and the adjustable portion 104 is coupled to the second bone portion. The implant 100 having the housing 102 and the adjustable portion 104 moveable relative to the housing 102 is adjusted. A position of the actuator 121 configured to cause movement of the adjustable portion 104 relative to the housing 102 is measured via the sensor 336. A position of the actuator 414, 416 of an external adjustment device 400 configured to actuate the actuator 121 of the implant 100 is measured via the sensor 346. At least one of a distraction force a distraction torque, a compression force, and compression torque is determined based on a position of the actuator 121 and a position of the actuator 414, 416. As discussed herein, the sensor 336 includes a unidirectional hall effect sensor and the sensor 346 includes an omnidirectional hall effect sensor. The controller 302 is positioned between the sensors 336, 346 and determines at least one of a distraction force, a distraction torque, compression force, and compression torque. at least one of the distraction force, distraction torque, compression force, and compression torque is sent via the transducer 304 to an external interface device 305 and via the transceiver 307 (FIGS. 7 and 9). A medical professional can then view the determined distraction force, distraction torque, compression force, and/or compression torque via the external interface device. The medical professional can then determine treatment instructions based on such data. The implant 100 and/or external adjustment device 400 can receive the treatment instructions and adjust the implant 100 based on the treatment instructions.


2. Dual Implant-Magnet Sensing


In an alternative embodiment for measuring loads within the implant 100, dual multi-dimensional sensors 341, 343 are utilized to obtain two separate magnetic field readings associated with the implant's magnet 123 relative to the external magnet 440 of the external adjustment device 400, as shown in the bottom half of FIG. 12. Unlike the prior arrangement, this arrangement determines one or more associated forces independently of the position of the external adjustment device 400. Instead, the two sensors 341, 343 are strategically located at different positions in the housing to read the magnetic field (i.e., field vectors) of the implant magnet 123 relative to the external magnet 440 of the external adjustment device 400, e.g., as the external magnet interacts with the implant magnet 123. The sensed magnetic field results can then be evaluated by the controller 102 to determine load values (i.e., forces). Multi-dimensional sensors 341, 343 may for example include three-dimensional or multi-axis hall effect sensors configured to read field vectors in multiple dimensions.


This approach is further described with reference to the bottom half of FIG. 12. When the moment of the implant magnet 123 follows that of the external magnet, the magnetic field vectors or lines are the same. However, when the moment of the implant magnet 123 lags the moment of the external magnet 440, the vectors 345 near the implant magnet will lag behind the vectors 347 farther from the implant magnet 123. That is, magnetic field lines are parallel to the axes of the implant when the two moments are pointing in the same direction. However, when the moment of the implant magnet lags, the field lines would look helical or skewed as shown. The rotation of the moment may be described with the formula:

Theta=tangent(magnitude of x/magnitude of y).


In certain embodiments, the moment 347 of the sensor 343 further away from the implant magnet 123 is used as the reference, and when the sensor 341 closer to the implant magnet observes a lag, the angle is subtracted from the reference. The lag is, e.g., caused by a counter-torque, which is directly proportional to the counter-force, which is the resisting force against the soft tissues when the implant 100 is distracted.


To correlate the angular lag to a linear force, the linear force can be calibrated by a test instrument, e.g., an ERC fixture, which is instrumented with a force gauge that can constrain the two ends of the implant 100. When the implant 100 is extended by the ERC, the linear force is recorded. The same approach can monitor stalling and coupling/decoupling between two magnets and can locate the moving external magnet in space.


D. Half-Cylinder Piezo Signal Transmission


Turning to FIGS. 13-14, in yet another embodiment, the described transducer 304 may include a signal transmission device 500 that includes a half-cylinder piezoelectric transducer 502 for communicating data. Like transducer 304 of FIGS. 4 and 7, the signal transmission device 500 is configured to transmit data associated with the adjustable implant 100 to an external adjustment device 400 or an external interface device 305, e.g., to be viewed by a medical professional and/or a patient. For example, a transceiver 307 (FIG. 7) positioned external the patient can be used to demodulate the signal transmitted by the signal transmission device 500 into meaningful data digestible and interpretable, e.g., by the external interface device 305. Once the signal is demodulated, the transceiver 307 can send the demodulated data to the external interface device 305.


The signal transmission device 500 is configured to transmit a directional signal relative to the patient having the adjustable implant 100 implanted therein. As shown in FIGS. 13 and 14, the signal transmission device 500 may include a half-cylinder piezoelectric transducer 502 positioned within a package 504 that is positioned within the housing 102. Housing 102 may comprise any metallic housing. In one embodiment, the housing 102 can include a titanium housing. In another embodiment, the housing 102 can include non-ferrous, biocompatible metal such as, for example, a Biodur® (Biodur is a registered trademark of CRS HOLDINGS, INC.) housing. As shown, the half-cylinder piezoelectric transducer 502 includes an inner diameter 506 (FIG. 14) and an outer diameter 508 (FIG. 14). A metal backing 510 is positioned adjacent the inner diameter 506. The metal backing 510 can include, for example, a stainless steel. The metal backing 510 may be a half-cylinder metal backing. Disposed between the half piezoelectric transducer 502 and the metal backing 510 is a filler 511 (FIG. 14), which can include any viscous material that closely matches the acoustic impedance of the piezoelectric transducer and housing including, e.g., water, mineral oil, acoustic gel, etc. In an illustrative embodiment, the filler 511 can include, e.g., at least one of: a bio-compatible epoxy, fluorinated oil such as Krytox® (Krytox is a registered trademark of E. I. DU PONT DE NEMOURS AND COMPANY), and silicon oil. The package 512 is positioned within the housing 102 and substantially surrounding the half-cylinder piezoelectric transducer 502 and the metal backing 510. As shown, the package 504 is positioned adjacent the outer diameter of 508 of the half-cylinder piezoelectric transducer 502. Disposed between the half piezoelectric transducer 502 and the semiconductor package 504 is a filler 513. The package 504 can also house the power supply components 310. The filler 513 can include at least one of: a super epoxy, fluorinated oil such as Krytox® (Krytox is a registered trademark of E. I. DU PONT DE NEMOURS AND COMPANY), and silicon oil. The half-cylinder piezoelectric transducer 502 can be a 1 KHz-10 MHz piezoelectric transducer, e.g., 250 KHz. A filler 514 may be positioned within the housing 504 and substantially surround the package 504, the half-cylinder piezoelectric transducer 502 and the metal backing 510. In one embodiment the filler 514 include at least one of: super epoxy, fluorinated oil such as Krytox® (Krytox is a registered trademark of E. I. DU PONT DE NEMOURS AND COMPANY), and silicon oil.


As shown by arrows 505 in FIG. 14, this configuration of the signal transmission device 500 ensures strong signal in a desired direction relative to the patient (e.g., laterally from patient) so that it can be picked up by the external interface device 305 and/or transceiver 307. In this half cylinder arrangement, metal backing 510 acts as reflector such that signals 505 are concentrated, e.g., within a 180 degree radius. Accordingly, strong signal strength can be achieved with less power relative to a full 360 degree arrangement. Note that while signal transmission device 500 includes a half-cylinder (i.e., 180 degree) piezoelectric transducer 502, other partial-cylinder transducers could likewise be utilized, e.g., a three-quarter cylinder transducer, a one quarter cylinder transducer, etc.


In still further embodiments, the piezoelectric transducer can have any cross-sectional shape that conforms to the implant housing, e.g., oval, rectangular, polygonal, etc. In such cases, the transducer can likewise be configured to directionally focus signals in a manner similar to the half piezo arrangement. For instance, a one third oval, half oval, etc., cross-section could be implemented to focus signals in a desired direction (i.e., less than 360 degrees). In still further cases, a phase array transducer arrangement could be implemented to channel signals in a desired direction.


Also positioned within the signal transmission device 500 is a printed circuit board 516. The printed circuit board 516 can include the controller 302 (FIGS. 4-9) thereon. Further, the printed circuit board 516 can include the switch 344 (FIGS. 4 and 8) and the sensor 346 (FIGS. 8-9) when used.


In an illustrative embodiment, external transceiver 307 of external interface device 305 may be placed laterally on a body part such as a leg. In this case, the external interface device 305 is an independent standalone device separate from an external adjustment device 400 that may be used at the same time. The transceiver can be configured to take up the different space than the external adjustment device 400, which, e.g., will be sitting anterior to the leg.


E. Energy Harvesting System


As shown in FIG. 15, in another embodiment, the implant 100 can include and energy harvesting system that captures energy, e.g., machinal energy, heat energy, etc., associated with the implant 100 and converts the energy to electrical energy. The system may include an energy harvesting component 602, a power management unit 600, energy storage components 310 and sensors 606. The energy storage components 310 may for example include a battery that supplies electricity to loads 604, such as the various smart components. Sensors 606 may be used to facilitate management of the system, e.g., determine amounts of energy being harvested, used, etc.


In one embodiment, a transducer 304 (FIG. 4) and/or half-cylinder piezoelectric transducer 502 (FIGS. 13 and 14) can be configured to harvest energy imparted on the implant 100 during movement of the patient having the implant 100 implanted therein. That is, the transducer 304, 502 itself acts as the energy harvesting component 602. In this embodiment, the power storage components 310 are configured to store energy harvested from the transducer 304. However, it is to be understood that an energy harvesting component 602 separate from the transducer 304 can be provided without departing from aspects of the disclosure such as, for example, a magnet and coil, an electromagnet, and a RF harvester. With further reference to FIG. 4, the energy harvested by the transducer 304 can be configured to provide power for at least one of the controller 302, the transducer 304, the load cell 306, one or more sensors 336, 346 and/or any other smart components of the implant 100. Wiring may couple the transducer 304 and the energy storage components 310 such that the energy harvested by the transducer 304 can be transferred to the energy storage components 310 and back to the transducer 304 to power the transducer 304 when needed. The wiring can include a printed circuit board having a power management unit 600 thereon configured to adjust a voltage of the energy harvested by the energy harvesting component. As shown in FIG. 15, the power management unit 600 collects the voltage signal from the energy harvesting component 602 (e.g., transducer 304, 502) and adjusts or modifies the voltage harvested to a level that can be stored within the energy storage components 310.


The energy harvesting component 602 is placed to capture the surrounding energy, e.g., vibration, electromagnetic, magnetic, heat, etc., and convert it into an electrical energy. Voltage is induced, e.g., when the transducer 304 is going through a strain. Often the voltage is in the format of AC swinging between negative and positive potentials. In one embodiment, a rectifier (is used to collect just the positive voltage, otherwise the positive and negative cancels out. To store the power efficiently into an energy format, the raw power is often regulated with a current flow manager. Switches are placed to traffic the inflow and outflow of electrical power to loads 604, such as one of the smart components. In the case where transducer 304 acts as the energy harvester, the same or another piezoelectric transducer may be used for communication, e.g., to induce ultrasound signals.


There is also wiring coupling the energy storage components 310 to the controller 302, sensors 336, 346 and load cell 306 such that the energy storage components 310 can supply the harvested energy to those components as well. As noted, the transducer 304 can be a piezoelectric transducer. In this embodiment, the transducer 304 is coupled to an internal surface of the housing 102. More specifically, the transducer 304 is coupled to an internal surface of the housing 102 at a location of the implant 100 that receives tension or compressive stresses due to movement of the patient. The transducer 304 harvests energy from stress generated by the implant 100 due to the bending force imparted on the implant 100 during movement of the patient. Therefore, in this embodiment, the implant 100 smart components are powered by the energy harvested directly from movement of the patient. In certain embodiments, the transducer 304, 502 can act as both a communication device and an energy harvesting device. In other embodiments, implant 100 includes a first transducer for communication and a second transducer for energy harvesting.


An illustrative method using energy harvesting includes implanting the implant 100 within a patient, such as for example within an intramedullary canal of a bone. An osteotomy is performed to create a first bone portion and a second bone portion. The housing 102 is coupled to the first bone portion and the adjustable portion 104 is coupled to the second bone portion. The method further includes harvesting energy from stresses imparted on the implant 100 during movement by the patient having the implant 100 implanted therein and using the harvested energy to power at least one of the smart components. As discussed herein, the energy harvesting system can include the transducer 304 configured to send data to an external interface device 305 (FIGS. 7 and 9) via transceiver 307 (FIGS. 7 and 9) positioned external to the patient. The data can include at least one of: a distraction force, a distraction force, a distraction length, a compression force, a compression torque, a compression length, a compressive stress, a tension stress, a biological condition, and a position of the implant 100. A medical professional can then view the data and determine treatment instructions (e.g., a distraction length, a distraction time, a distraction force, compression length, compression time, compression force) and send such instructions to the implant 100 and/or external adjustment device 400 via the external interface device 305. The implant 100 is adjusted such that adjustable portion 104 moves relative to the housing 102. Thus, the second bone portion moves relative to the first bone portion.


F. Reed Switch


In various embodiments, the implant 100 can include a switch 344 such as that shown in FIG. 4 for preserving power when one or more of the smart components are not in use. In one example, the switch 344 can include an electrical switch such as a reed switch that is operated by an applied magnetic field (such as from an external adjustment device 400 having at least one magnet 440 therein). In this example, the reed switch can be a normally-open reed switch that is configured to close or complete the circuit upon application of a magnetic field. The switch 344 can for example be configured to activate any component, e.g., the controller 302, transducer 304, load cell 306, sensors, etc., when the external adjustment device 400 (FIGS. 17-19) is in proximity to the adjustable implant 100. The switch 344 can be configured to activate (i.e., turn on) when a threshold distance between the adjustable implant 100 and the external adjustment device 400 is reached (e.g., 2-4 inches). The switch 344 can be configured to deactivate components when the external adjustment device 400 is farther than or outside of the threshold distance relative to the adjustable implant 100 such that an activatable component is in a resting or off state when the external adjustment device 400 is farther than the threshold distance relative to the adjustable implant 100. The switch 344 is operatively coupled to the activatable components via wiring (not shown). The switch 344 can be utilized in conjunction with a power management system for some or all the components in the implant 100 that require power supply components 310. In certain embodiments, the reed switch 344 can be configured to activate the controller 302, and the controller 302 can in turn manage power for other smart components (e.g., turn them on and off as needed).


An illustrative method involving a reed switch includes providing the implant 100 including the housing 102 and the adjustable portion 104 moveable relative to the housing 102 upon application of a force supplied by an external adjustment device 400, a sensor 336 configured to sense monitor a position of the actuator 121 of the adjustable implant 100, and a controller 302 disposed within the housing 102 and communicatively coupled to the sensor 336. The method also includes implanting the implant 100 within a patient, such as for example within an intramedullary canal of a bone. An osteotomy is performed to create a first bone portion and a second bon portion. The housing 102 is coupled to the first bone portion and the adjustable portion 104 is coupled to the second bone portion. The method also includes activating at least one of the controller 302, transducer 304 and/or sensors when the external adjustment device 400 is within a threshold proximity to the implant 100. The method also includes deactivating the at least one of the controller 302, transducer 304, and/or sensors when the external adjustment device 400 is outside of a threshold proximity to the implant 100. In one embodiment, once activated via the reed switch when the external adjustment device 400 is within the threshold proximity, the sensor 336 senses the angular position of the actuator 121. The controller 302 is configured to receive the angular position data from the sensor 336 and digitize the data when the external adjustment device 400 is within the threshold proximity. The controller 302 is also configured to send the digitized data to the transducer 304 when the external adjustment device 400 is in proximity to the implant 100. In one embodiment, the transducer 304 is configured to communicate with the external interface device 305 via radiofrequency waves. In another embodiment, the transducer 304 is configured to communicate with the external interface device via ultrasound waves. The transducer 304 communicates the at least one of the distraction force, distraction torque, distraction length, compression force, compression torque, and compression length when the external adjustment device 400 is within a threshold distance relative to the adjustable implant.


G. External Interface Device



FIG. 16 depicts an illustrative external interface device 305 configured to interact with implant device 100 implanted in body 101. The external interface device 305 may comprise a handheld device that can be placed on or near the skin of a patient to allow a user to interact with (e.g., communicate, control, etc.) the controller in implant 100, e.g., via a transducer 304, 502. In certain embodiments, device 305 may include an external transceiver 307 configured to communicate (i.e., receive data and transmit data) with the implant 100. In certain embodiments, the transceiver 307 includes a transducer 309 capable of receiving or sending ultrasonic signals to and from a transducer 304, 502 in the implant 100. Device 305 may also include, e.g., a controller/GUI 311 that allows the operator to control and interact with the device 305, one or more power supply components 313, a processor 315, and a communication system 317. The external transceiver 307 may be configured to communicate, for example, via ultrasound, radiofrequency, or other types of signals. In the case where ultrasound is used, the transducer 309 can include any of the types of transducers discussed relative to the transducer 304, 502. The controller 311 is configured to manage the external interface device 305 and can include any of the types of controllers discussed relative to the controller 302 (FIG. 4). The power supply components 313 are configured to supply power for the external interface device 305 and can include any of the power supply components discussed relative to the power supply components 310 (FIG. 4). Device 305 may be configured to interface with a smart device 301 (e.g., a smart phone, tablet, laptop, etc.) that allows a user to view and manage information transmitted from the implant via device 305, including data generated by smart components. Smart device 301 may also be configured to send data and commands to the implant 100 via device 305. The smart device 301 may be implemented with a downloadable App. The smart device 301 allows for the patient or medical professional to easily interact with the implant 100 and external interface device 305. In some embodiments, the features of smart device 301 and external interface device 305 are integrated into a single device.


III. General External Adjustment Device Discussion


Actuation of the actuator 121 can be caused and controlled by an external adjustment device such as those described in U.S. Pat. No. 8,382,756 filed on Nov. 20, 2009, U.S. Pat. No. 9,248,043 filed Jun. 29, 2011, U.S. Pat. No. 9,078,711 filed on Jun. 6, 2012, U.S. Pat. No. 9,044,281 filed on Oct. 18, 2012, U.S. application Ser. No. 13/172,598 filed on Jun. 29, 2011, U.S. application Ser. No. 14/698,665 filed on Apr. 28, 2015, U.S. application Ser. No. 14/932,904 filed on Nov. 4, 2015, U.S. Ser. No. 16/004,099 filed on Dec. 12, 2016, and App. No. PCT/US2020/017338 filed on Feb. 7, 2020, all of which are incorporated herein by reference as if set forth in their entirety. external interface device 305


The external adjustment device 400, may include a housing 401 having a handle 402 and a display 403. The handle 402 is shown extending upwardly from the housing 401. In some embodiments, the display 403 may be integrated with the housing 401 of the external adjustment device 400. In the illustrated embodiment, the external adjustment device 400 is configured to receive a removable controller 410 having a display 403, with the display 403 being an integral part of the removable controller 410.


According to an exemplary embodiment, the controller 410 may be a handheld electronic device. The handheld electronic device may be, for example, a smartphone, a tablet, and any other known handheld electronic device. The handheld electronic device may contain and may be operatively connected to a display and/or one or more wireless communication protocols (e.g., Wi-Fi or Bluetooth®). The display of the handheld electronic device may be disposed adjacent to a top surface of the external adjustment device 400, such that the display 403 can communicate information to and receive instructions from a user during use.


For example, in some embodiments the display 403 may present to a user a graphical user interface (GUI). The display 403 may include one or more of a touchscreen or touchscreen technology, including, for example, capacitive touchscreen technology. The GUI may communicate adjustment instructions to a user which may correspond to a treatment regimen to guide the user in adjusting the adjustable implant in accordance with the treatment regimen. Additionally, the GUI may include one or more touchscreen digital buttons configured to activate and control the external adjustment device 400.



FIG. 17 shows a front view of the external adjustment device 400, the external adjustment device 400 including a power supply input 422 and a data connection port 412. Additionally, a bottom surface of the housing 401 is shown including a curvature configured to form to a patient's body and minimize a distance (GAP) between the magnet 440 and a magnet 118 (FIG. 3) of the adjustable implant 100 (FIG. 14). The power supply input 422 may be configured to removably receive an AC power supply. The data connection port 412 may be configured to removably receive a data communication cable. The data communication cable may be configured to connect the external adjustment device 400 to a tertiary device to one or more of update the controller 410 software and download data from the controller 410.



FIG. 18 shows a cross-sectional side view of the external adjustment device 400 in accordance with the first embodiment. The external adjustment device 400 shown including the housing 401, the controller 410, an internal power storage device 420, a motor 430, and at least one magnet 440.


The internal power storage device 420 and wireless communication capabilities of the controller 440, may provide for wireless operation of the external adjustment device 400. The internal power storage device 420 may negate the need for a power chord during operation. The controller 410 may provide a low voltage control system negating the need for a bulky external control module. And wireless communication capabilities, for example one or more of RF, Wi-Fi Bluetooth® may enable the external adjustment device 400 and the controller 410 for remote operation. The remote operation may be achieved by one or more of a tertiary device in the same room, and across the internet by a tertiary device on the other side of the globe.


In some embodiments, the controller 410 may be a control board disposed within the housing 401 of the external adjustment device 400. The display 403 may include any type of display 403, including for example: LED, LCD, OLED, and any other known display and touchscreen technology. The control interface board 411 may contain or be in communication with one or more communication circuit, for example, one or more of Wi-Fi, cellular networks, or Bluetooth®, enabling communication between the external adjustment device 400 and one or more tertiary devices.


In FIG. 18, the controller 410 is shown operably connected to a controller interface board 411 by at least one interconnect. In some embodiments, this connection may be established via a physical connection as illustrated, and in some embodiments, a wireless connection, for example, Bluetooth®. The control interface board 411 may be further connected to one or more of a power interface board 421, the power storage device 420, and the actuator 430.


The controller 410 may be remotely accessible and remotely controllable by a tertiary device allowing for remote operation of the external adjustment device 400 by a user from outside of a sterile field.


The external adjustment device 400 is also shown including an internal power storage device 420. The power storage device 420 may include a battery, a capacitor, and any other power storage device known and used in the art. The power storage device may be rechargeable and the external adjustment device 400 may include a recharging circuit configured to recharge the power storage device 420 using an external power source. The external power source, for example a power supply, may be operably connected to the recharging circuit of the power storage device via the power supply input. The power storage device 420, and/or at least a portion of the recharging circuit, may be disposed adjacent to a surface of the external adjustment device 400, enabling connection of a power supply charge cable to the external adjustment device 400. In some embodiments, the recharging circuit may enable wireless charging of the internal power storage device 420, using induction to wirelessly transfer power. In some embodiments, the recharging circuit may be part of and connected to one or more of the power distribution board 421 and the power storage device 400.


In the illustrated embodiment, the power storage device 420 is a battery. The battery 420 is mounted to a chassis of the external adjustment device 400, adjacent to a surface of the external adjustment device 400 enabling connection of a power supply to the external adjustment device 400 at a power supply input 422. The battery 420 includes a power interface board 421, configured to interface with and communicate power to the motor 430. The power interface board 421 may be operably coupled to one or more of the motor 430 and the control interface board 411. The power interface board 421 may also communicate electrical energy from one or more of a power supply input 422 and the power storage device 420, to the controller 410.


The actuator of the external adjustment device 400 includes an electronic motor 430. The driver of the external adjustment device 400 includes a magnet 440 rotatably coupled to the electronic motor 430. The motor 430 may be operably connected to one or more of the controller 410, the control interface board 411, the power interface board 421 and the internal power storage device 420. In the illustrated embodiment the electronic motor 430 is operably connected to the internal power storage device 420 by the power interface board 421. The power interface board 421 may include power distribution circuits to communicate electrical energy to the electronic motor 430 from one or more of the power supply input 422 and the internal power storage device 420. The power interface board 421 may also be operably connected to the control interface board 411, to relay control information from the controller 410 to the motor 430. In some embodiments, the controller 410 may be in direct communication with the motor 430, and in some embodiments the controller 410 may be connected to the electronic motor via a wireless connection, for example a Bluetooth® connection.


The motor 430 may include any type of motor capable of rotating the magnet 440. The motor 430 is an electric motor and may include a rotational speed sensor 432. The rotational speed sensor 432 connected to and in communication with one or more of the control interface board 411 and the controller 410. In some embodiments, the internal speed sensor 432 may include for example one or more of an encoder and a digital output of an electronic motor. In some embodiments, the motor 430 is configured to communicate rotational speed data to the controller 410 wirelessly.



FIG. 19 shows an enhanced cross-sectional view of the motor 430 and the magnet 440 of the external adjustment device 400 in accordance with a first embodiment. The magnet 440 is shown rotatably coupled to the motor 430 by one or more couplings 431. In the illustrated embodiment, the magnet 440 includes an internal cavity 441 having an internal surface 442 and having a tapered profile. A magnet drive shaft 433 is shown including a magnet contact surface 434 having a tapered profile. The tapered profile of the magnet drive shaft 433 is configured to communicate with the tapered profile of the internal surface 442 of the magnet 440. This enables the magnet 440 to be secured to the magnet drive shaft 433 by a friction fit, the magnet 440 configured to be held onto the magnet drive shaft 433 by a cap 435 and the communicating tapered profiles. In some embodiments, the magnet 440 may be attached to the magnet drive shaft 433 using an adhesive material.


The magnet 440 may comprise any magnetic element including a radially polarized cylindrical magnet, a permanent magnet, an electromagnet, and any other magnetic element known and used in the art. The magnet 440 is configured to magnetically couple with a permanent magnet 118 of an adjustable implant 100 and to rotate the permanent magnet 118 and adjust the adjustable implant 100. Upon a rotation of the magnet 440, a rotating magnetic field will be generated, placing a force on the magnetically coupled permanent magnet 118 of the adjustable implant 100, thereby inducing a rotation of the permanent magnet 118 and subsequent adjustment of the adjustable implant 100.


In some embodiments, the external adjustment device 400 includes one or more sensors configured to monitor a rotational speed of the magnet 440. In some embodiments, the sensors include magnetic sensors, for example Hall-Effect sensors disposed on one or more of the housing 401, a plate, and a chassis, and may be placed adjacent to the magnet 440. In some embodiments, the sensors include photo-sensors. The magnet may include one or more circular optical encoder strips to work in conjunction with the photo-sensors. U.S. patent application Ser. No. 14/932,904 describes various systems and methods for non-invasively detecting the force generated by a non-invasively adjustable implant, the entire contents of which are hereby incorporated by reference.


In the illustrated embodiment the external adjustment device 400 includes a motor 430 having one or more rotational speed sensor 432 configured to detect a change in a motor angular velocity (V), and thereby as described below non-invasively detect a rotation of the permanent magnet 118 of the adjustable implant 100. The motor 430 has torque characteristics that allows for little variation in motor angular velocity (V) during a motor rotation and corresponding magnet 440 rotation, when there is no implant or ferrous material located near the ERC magnet or magnetically coupled to the magnet 440.


When an adjustable implant 100 having a magnet 118 is in close proximity to the rotating magnet 440, and for example magnetically coupled to the magnet 440, the magnetic poles of both magnets cause a changing load on the motor 430 twice per revolution. This causes the magnet 440 to increase or decrease in angular velocity, with the variations detectable by the rotational speed sensor 432.


One or more example computing environments 100 can be used to implement techniques described herein. The computing environment 100 is a set of one or more virtual or physical computers configured to cause output based on data. In many examples, the computing environment 100 is a workstation, desktop computer, laptop computer, server, mobile computer, smartphone, tablet, embedded computer, other computers, or combinations thereof. In other examples, the computing environment is a virtual machine, group of computers, other computing environments, or combinations thereof.


In the illustrated example, the computing environment 1000 includes one or more processors 1010, memory 1020, and an interface 1030 coupled to a network 1002. The network 1002 is a group of communicatively coupled computing environments and associated hardware, such as a local area network, the Internet, other networks, or combinations thereof.


The one or more processors 1010 are one or more physical or virtual components configured to obtain and execute instructions. In many examples, the one or more processors 1010 are central processing units, but can take other forms such as microcontrollers, microprocessors, graphics processing units, tensor processing units, other processors, or combinations thereof.


The memory 1020 is one or more physical or virtual components configured to store information, such as data or instructions. In some examples, the memory 1020 includes the computing environment's main memory (e.g., random access memory) or long-term storage memory (e.g., a solid state drive). The memory can be transitory or non-transitory computer-readable or processor-readable storage media.


The interface 1030 is a set of one or more components by which the computing environment 1000 can provide output or receive input. For example, the interface 1030 can include one or more user input components, such as one or more sensors, buttons, pointers, keyboards, mice, gesture controls, touch controls (e.g., touch-sensitive strips or touch screens), eye trackers, voice recognition controls (e.g., microphones coupled to appropriate natural language processing components), other user input components, or combinations thereof. The interface 1030 can include one or more user output components, such as one or more lights, displays, speakers, haptic feedback components, other user output components, or combinations thereof. The interface 1030 can further include one or more components configured to provide output to or receive input from other devices, such as one or more ports (e.g., USB ports, THUNDERBOLT ports, serial ports, parallel ports, Ethernet ports) or wireless communication components (e.g., components configured to communicate according to one or more radiofrequency protocols, such as WI-FI, BLUETOOTH, ZIGBEE, or other protocols).


The computing environment 1000 can include one or more additional components or connections among components (e.g., busses).


The computing environment 1000 can be configured to implement one or more aspects described herein. Algorithms, steps, or procedures for so configuring the computing environment and performing functions described herein can be understood from the description herein in view of knowledge in the art of how to implement computer functions.


The computing environment 1000 can be configured to implement one or more aspects described herein. Algorithms, steps, or procedures for so configuring the computing environment and performing functions described herein can be understood from the description herein in view of knowledge in the art of how to implement computer functions.


Example techniques for implementing such computer functions include frameworks and technologies offering a full stack of plug-and-play capabilities for implementing desktop and browser-based applications (e.g., the applications implementing aspects described herein). The frameworks can provide a desktop web application featuring or using an HTTP server such as NODEJS or KATANA and an embeddable web browser control such as the CHROMIUM EMBEDDED FRAMEWORK or the JAVA/.NET CORE web view. The client-side frameworks can extend that concept by adding plug-and-play capabilities to desktop and the web shells for providing apps capable of running both on the desktop and as a web application. One or more components can be implemented using a set of OWIN (Open Web Interface for .NET) components built by MICROSOFT targeting the traditional .NET runtime. KATANA, and by definition OWIN, allow for chaining together middleware (OWIN-compliant modules) into a pipeline thus offering a modular approach to building web server middleware. For instance, the client-side frameworks can use a Katana pipeline featuring modules such as SIGNALR, security, an HTTP server itself. The plug-and-play capabilities can provide a framework allowing runtime assembly of apps from available plugins. An app built atop of a plug-and-play framework can have dozens of plugins, with some offering infrastructure-level functionality and other offering domain-specific functionality. The CHROMIUM EMBEDDED FRAMEWORK is an open source framework for embedding the CHROMIUM browser engine with bindings for different languages, such as C # or JAVA. OWIN is a standard for an interface between .NET web applications and web servers aiming at decoupling the relationship between ASP.NET applications and IIS by defining a standard interface.


Further example techniques for implementing such computer functions or algorithms include frameworks and technologies provided by or in conjunction with programming languages and associated libraries. For example, languages such as C, C++, C #, PYTHON, JAVA, JAVASCRIPT, RUST, assembly, HASKELL, other languages, or combinations thereof can be used. Such languages can include or be associated with one or more standard libraries or community provided libraries. Such libraries in the hands of someone skilled in the art can facilitate the creation of software based on descriptions herein, including the receiving, processing, providing, and presenting of data. Example libraries for PYTHON and C++ include OPENCV (e.g., which can be used to implement computer vision and image processing techniques), TENSORFLOW (e.g., which can be used to implement machine learning and artificial intelligence techniques), and GTK (e.g., which can be used to implement user interface elements). Further examples include NUMPY for PYTHON (e.g., which can be used to implement data processing techniques). In addition, other software can provide application programming interfaces that can be interacted with to implement one or more aspects described herein. For example, an operating system for the computing environment (e.g., WINDOWS by MICROSOFT CORP., MACOS by APPLE INC., or a LINUX-based operating system such as UBUNTU by CANONICAL LTD.) or another component herein (e.g., an operating system of a robot, such as IIQKA.OS or SUNRISE.OS by KUKA ROBOTICS CORPORATION where the robot is a model of KUKA ROBOTICS CORPORATION) can provide application programming interfaces or libraries to usable to implement aspects described herein. As a further example, a provider of a navigation system, laser console, wireless card, display, motor, sensors, or another component may not only provide hardware components (e.g., sensor, a camera, wireless card, motor, or laser generator), but also software components (e.g., libraries, drivers, or applications) usable to implement features with respect to the components.


In the descriptions above and in the claims, phrases such as “at least one of” or “one or more of” may occur followed by a conjunctive list of elements or features. The term “and/or” may also occur in a list of two or more elements or features. Unless otherwise implicitly or explicitly contradicted by the context in which it is used, such a phrase is intended to mean any of the listed elements or features individually or any of the recited elements or features in combination with any of the other recited elements or features. For example, the phrases “at least one of A and B;” “one or more of A and B;” and “A and/or B” are each intended to mean “A alone, B alone, or A and B together.” A similar interpretation is also intended for lists including three or more items. For example, the phrases “at least one of A, B, and C;” “one or more of A, B, and C;” and “A, B, and/or C” are each intended to mean “A alone, B alone, C alone, A and B together, A and C together, B and C together, or A and B and C together.” Use of the term “based on,” above and in the claims is intended to mean, “based at least in part on,” such that an unrecited feature or element is also permissible.


The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the disclosure. As used herein, the terms “first,” “second,” and the like, do not denote any order, quantity, or importance, but rather are used to distinguish one element from another, and the terms “a” and “an” herein do not denote a limitation of quantity, but rather denote the presence of at least one of the referenced items. It will be further understood that the terms “comprises” and/or comprising,” when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups. As used herein, “substantially” refers to largely, for the most part, entirely specified or any slight deviation which provides the same technical benefits of the disclosure.


The implementations set forth in the foregoing description do not represent all implementations consistent with the subject matter described herein. Instead, they are merely some examples consistent with aspects related to the described subject matter. Although a few variations have been described in detail herein, other modifications or additions are possible. In particular, further features and/or variations can be provided in addition to those set forth herein. For example, the implementations described above can be directed to various combinations and sub-combinations of the disclosed features and/or combinations and sub-combinations of one or more features further to those disclosed herein. In addition, the logic flows depicted in the accompanying figures and/or described herein do not necessarily require the particular order shown, or sequential order, to achieve desirable results. The scope of the following claims may include other implementations or embodiments.

Claims
  • 1. An adjustable implant comprising: a housing having a first set of apertures, each configured to receive one of a plurality of bone screws;an adjustable portion movable relative to the housing;an actuator positioned within the housing and configured to cause movement of the adjustable portion relative to the housing;a sensor positioned adjacent to the actuator and configured to monitor an angular position of the actuator; anda load cell, disposed within the housing, having a second set of apertures that line up with the first set of apertures, each of the second set of apertures configured to receive one of the plurality of bone screws, wherein a diameter of the second set of apertures is smaller than a diameter of the first set of apertures so that the plurality of bone screws anchor primarily to the load cell.
  • 2. The adjustable implant of claim 1, further comprising: a controller communicatively coupled to the sensor and configured to receive angular position data from the sensor.
  • 3. The adjustable implant of claim 2, wherein the controller is configured to determine a number of rotations of the actuator in response to processing the angular position data.
  • 4. The adjustable implant of claim 3, wherein the controller is configured to calculate a distraction length or a compression length of the adjustable implant based on the number of rotations of the actuator.
  • 5. The adjustable implant of claim 4, further comprising: a transducer configured to send data including at least one of the number of rotations, distraction length and compression length to an external interface device.
  • 6. The adjustable implant of claim 1, wherein the sensor includes a hall effect sensor that detects a magnetic field of an actuator magnet.
  • 7. The adjustable implant of claim 2, wherein the hall effect sensor includes one of a unidirectional hall effect sensor, a rotary hall effect sensor and a rotary hall effect sensor having a 4-hall element arrangement.
  • 8. The adjustable implant of claim 2, further comprising a reed switch configured to power on the controller in response to an external device being within a threshold distance of the adjustable implant and power off the controller in response to the external device being outside the threshold distance of the adjustable implant.
  • 9. The adjustable implant of claim 1, wherein the load cell has a strain gauge for measuring a linear force imparted on the housing.
  • 10. A method comprising: adjusting an adjustable implant, the adjustable implant including: a housing having a first set of apertures, each configured to receive one of a plurality of bone screws;an adjustable portion moveable relative to the housing;an actuator positioned within the housing and configured to cause movement of the adjustable portion relative to the housing;a sensor positioned adjacent to the actuator and configured to monitor an angular position of the actuator; anda load cell, disposed within the housing, having a second set of apertures that line up with the first set of apertures, each of the second set of apertures configured to receive one of the plurality of bone screws, wherein a diameter of the second set of apertures is smaller than a diameter of the first set of apertures so that the plurality of bone screws anchor primarily to the load cell,determining a number of rotations of the actuator based on monitoring of the angular position; andcalculating a distraction length or a compression length of the adjustable implant based upon the number of rotations of the actuator.
  • 11. The method of claim 10, wherein the adjustable implant further includes a controller positioned within the housing and communicatively coupled to the sensor.
  • 12. The method of claim 10, wherein the sensor includes a hall effect sensor.
  • 13. The method of claim 10, further comprising: sending data that includes at least one of the number of rotations, the distraction length or the compression length to an external interface device.
  • 14. The method of claim 13, wherein the adjustable implant further includes a transducer positioned within the housing for sending data.
  • 15. The method of claim 13, further comprising receiving treatment instructions from the external interface device to adjust the adjustable portion.
  • 16. The method of claim 15, wherein the treatment instructions are based on the calculated distraction length or compression length.
  • 17. The method of claim 10, wherein the controller and sensor are activated and deactivated by a reed switch in response to a proximity of an external device.
CROSS REFERENCE TO RELATED APPLICATIONS

The present application claims the benefit of U.S. Provisional Application No. 63/152,562, filed Feb. 23, 2021.

US Referenced Citations (659)
Number Name Date Kind
2702031 Wenger Feb 1955 A
3111945 Von Solbrig Nov 1963 A
3372476 Peiffer Mar 1968 A
3377576 Langberg Apr 1968 A
3512901 Law May 1970 A
3597781 Eibes Aug 1971 A
3900025 Barnes, Jr. Aug 1975 A
3915151 Kraus Oct 1975 A
RE28907 Eibes et al. Jul 1976 E
3976060 Hildebrandt et al. Aug 1976 A
4010758 Rockland et al. Mar 1977 A
4056743 Clifford et al. Nov 1977 A
4068821 Morrison Jan 1978 A
4078559 Nissinen Mar 1978 A
4204541 Kapitanov May 1980 A
4357946 Dutcher et al. Nov 1982 A
4386603 Mayfield Jun 1983 A
4448191 Rodnyansky et al. May 1984 A
4486176 Tardieu et al. Dec 1984 A
4501266 McDaniel Feb 1985 A
4522501 Shannon Jun 1985 A
4537520 Ochiai et al. Aug 1985 A
4550279 Klein Oct 1985 A
4561798 Elcrin et al. Dec 1985 A
4573454 Hoffman Mar 1986 A
4592355 Antebi Jun 1986 A
4595007 Mericle Jun 1986 A
4642257 Chase Feb 1987 A
4658809 Ulrich et al. Apr 1987 A
4700091 Wuthrich Oct 1987 A
4747832 Buffet May 1988 A
4854304 Zielke Aug 1989 A
4904861 Epstein et al. Feb 1990 A
4931055 Bumpus et al. Jun 1990 A
4940467 Tronzo Jul 1990 A
4957495 Kluger Sep 1990 A
4973331 Pursley et al. Nov 1990 A
5010879 Moriya et al. Apr 1991 A
5030235 Campbell, Jr. Jul 1991 A
5041112 Mingozzi et al. Aug 1991 A
5064004 Lundell Nov 1991 A
5074882 Grammont et al. Dec 1991 A
5092889 Campbell, Jr. Mar 1992 A
5133716 Plaza Jul 1992 A
5142407 Varaprasad et al. Aug 1992 A
5156605 Pursley et al. Oct 1992 A
5263955 Baumgart Nov 1993 A
5290289 Sanders et al. Mar 1994 A
5304210 Crook Apr 1994 A
5306275 Bryan Apr 1994 A
5330503 Yoon Jul 1994 A
5334202 Carter Aug 1994 A
5336223 Rogers Aug 1994 A
5356411 Spievack Oct 1994 A
5356424 Buzerak et al. Oct 1994 A
5364396 Robinson et al. Nov 1994 A
5403322 Herzenberg et al. Apr 1995 A
5429638 Muschler et al. Jul 1995 A
5437266 McPherson et al. Aug 1995 A
5456724 Yen et al. Oct 1995 A
5466261 Richelsoph Nov 1995 A
5468030 Walling Nov 1995 A
5480437 Draenert Jan 1996 A
5509888 Miller Apr 1996 A
5516335 Kummer et al. May 1996 A
5527309 Shelton Jun 1996 A
5536269 Spievack Jul 1996 A
5549610 Russell et al. Aug 1996 A
5573012 McEwan Nov 1996 A
5575790 Chen et al. Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5620445 Brosnahan et al. Apr 1997 A
5620449 Faccioli et al. Apr 1997 A
5626579 Muschler et al. May 1997 A
5626613 Schmieding May 1997 A
5632744 Campbell, Jr. May 1997 A
5659217 Petersen Aug 1997 A
5662683 Kay Sep 1997 A
5672175 Martin Sep 1997 A
5672177 Seldin Sep 1997 A
5700263 Schendel Dec 1997 A
5704938 Staehlin et al. Jan 1998 A
5704939 Justin Jan 1998 A
5720746 Soubeiran Feb 1998 A
5743910 Bays et al. Apr 1998 A
5762599 Sohn Jun 1998 A
5771903 Jakobsson Jun 1998 A
5810815 Morales Sep 1998 A
5827286 Incavo et al. Oct 1998 A
5830221 Stein et al. Nov 1998 A
5879375 Larson, Jr. et al. Mar 1999 A
5902304 Walker et al. May 1999 A
5935127 Border Aug 1999 A
5945762 Chen et al. Aug 1999 A
5961553 Coty et al. Oct 1999 A
5976138 Baumgart et al. Nov 1999 A
5979456 Magovern Nov 1999 A
6022349 McLeod et al. Feb 2000 A
6033412 Losken et al. Mar 2000 A
6034296 Elvin et al. Mar 2000 A
6102922 Jakobsson et al. Aug 2000 A
6106525 Sachse Aug 2000 A
6120509 Michelson et al. Sep 2000 A
6126660 Dietz Oct 2000 A
6126661 Faccioli et al. Oct 2000 A
6138681 Chen et al. Oct 2000 A
6139316 Sachdeva et al. Oct 2000 A
6162223 Orsak et al. Dec 2000 A
6183476 Gerhardt et al. Feb 2001 B1
6200317 Aalsma et al. Mar 2001 B1
6234956 He et al. May 2001 B1
6241730 Alby Jun 2001 B1
6245075 Betz et al. Jun 2001 B1
6315784 Djurovic Nov 2001 B1
6319255 Grundei et al. Nov 2001 B1
6331744 Chen et al. Dec 2001 B1
6336929 Justin Jan 2002 B1
6343568 McClasky Feb 2002 B1
6358283 Hogfors et al. Mar 2002 B1
6375682 Fleischmann et al. Apr 2002 B1
6389187 Greenaway et al. May 2002 B1
6400980 Lemelson Jun 2002 B1
6402753 Cole et al. Jun 2002 B1
6409175 Evans et al. Jun 2002 B1
6416516 Stauch et al. Jul 2002 B1
6499488 Hunter et al. Dec 2002 B1
6499907 Baur Dec 2002 B1
6500110 Davey et al. Dec 2002 B1
6508820 Bales Jan 2003 B2
6510345 Van Bentem Jan 2003 B1
6537196 Creighton, IV et al. Mar 2003 B1
6554831 Rivard et al. Apr 2003 B1
6565573 Ferrante et al. May 2003 B1
6565576 Stauch et al. May 2003 B1
6582313 Perrow Jun 2003 B2
6583630 Mendes et al. Jun 2003 B2
6605089 Michelson Aug 2003 B1
6616669 Ogilvie et al. Sep 2003 B2
6626917 Craig Sep 2003 B1
6656135 Zogbi et al. Dec 2003 B2
6656194 Gannoe et al. Dec 2003 B1
6667725 Simons et al. Dec 2003 B1
6673079 Kane Jan 2004 B1
6702816 Buhler Mar 2004 B2
6706005 Roy et al. Mar 2004 B2
6706042 Taylor Mar 2004 B2
6709293 Mori et al. Mar 2004 B2
6730087 Butsch May 2004 B1
6761503 Breese Jul 2004 B2
6769499 Cargill et al. Aug 2004 B2
6789442 Forch Sep 2004 B2
6796984 Soubeiran Sep 2004 B2
6802844 Ferree Oct 2004 B2
6809434 Duncan et al. Oct 2004 B1
6835207 Zacouto et al. Dec 2004 B2
6852113 Nathanson et al. Feb 2005 B2
6918838 Schwarzler et al. Jul 2005 B2
6918910 Smith et al. Jul 2005 B2
6921400 Sohngen Jul 2005 B2
6923951 Contag et al. Aug 2005 B2
6971143 Domroese Dec 2005 B2
7001346 White Feb 2006 B2
7007699 Martinelli et al. Mar 2006 B2
7008425 Phillips Mar 2006 B2
7011658 Young Mar 2006 B2
7029472 Fortin Apr 2006 B1
7029475 Panjabi Apr 2006 B2
7041105 Michelson May 2006 B2
7060080 Bachmann Jun 2006 B2
7063706 Wittenstein Jun 2006 B2
7105029 Doubler et al. Sep 2006 B2
7105968 Nissen Sep 2006 B2
7114501 Johnson et al. Oct 2006 B2
7115129 Heggeness Oct 2006 B2
7135022 Kosashvili et al. Nov 2006 B2
7160312 Saadat Jan 2007 B2
7163538 Altarac et al. Jan 2007 B2
7172594 Biscup Feb 2007 B2
7182736 Roy et al. Feb 2007 B2
7189005 Ward Mar 2007 B2
7191007 Desai et al. Mar 2007 B2
7218232 DiSilvestro et al. May 2007 B2
7238191 Bachmann Jul 2007 B2
7241300 Sharkawy et al. Jul 2007 B2
7243719 Baron et al. Jul 2007 B2
7255682 Bartol, Jr. et al. Aug 2007 B1
7282023 Frering Oct 2007 B2
7285087 Moaddeb et al. Oct 2007 B2
7302015 Kim et al. Nov 2007 B2
7302858 Walsh et al. Dec 2007 B2
7314443 Jordan et al. Jan 2008 B2
7333013 Berger Feb 2008 B2
7351244 Hamada Apr 2008 B2
7357037 Hnat et al. Apr 2008 B2
7357635 Belfor et al. Apr 2008 B2
7360542 Nelson et al. Apr 2008 B2
7390007 Helms et al. Jun 2008 B2
7390294 Hassler, Jr. Jun 2008 B2
7402134 Moaddeb et al. Jul 2008 B2
7402176 Malek Jul 2008 B2
7429259 Cadeddu et al. Sep 2008 B2
7445010 Kugler et al. Nov 2008 B2
7455672 Michelson Nov 2008 B2
7458981 Fielding et al. Dec 2008 B2
7485149 White Feb 2009 B1
7489495 Stevenson Feb 2009 B2
7491179 Roy et al. Feb 2009 B2
7530981 Kutsenko May 2009 B2
7531002 Sutton et al. May 2009 B2
7553298 Hunt et al. Jun 2009 B2
7561916 Hunt et al. Jul 2009 B2
7611526 Carl et al. Nov 2009 B2
7615070 Biscup Nov 2009 B2
7618435 Opolski Nov 2009 B2
7658754 Zhang et al. Feb 2010 B2
7666184 Stauch Feb 2010 B2
7666210 Franck et al. Feb 2010 B2
7678136 Doubler et al. Mar 2010 B2
7678139 Garamszegi et al. Mar 2010 B2
7708737 Kraft et al. May 2010 B2
7708762 McCarthy et al. May 2010 B2
7727143 Birk et al. Jun 2010 B2
7753913 Szakelyhidi, Jr. et al. Jul 2010 B2
7753915 Eksler et al. Jul 2010 B1
7756579 Nitzan et al. Jul 2010 B2
7762998 Birk et al. Jul 2010 B2
7763075 Navarro et al. Jul 2010 B2
7763076 Navarro et al. Jul 2010 B2
7763080 Southworth Jul 2010 B2
7766855 Miethke Aug 2010 B2
7771478 Navarro et al. Aug 2010 B2
7771480 Navarro et al. Aug 2010 B2
7775215 Hassler, Jr. et al. Aug 2010 B2
7776068 Ainsworth et al. Aug 2010 B2
7776075 Bruneau et al. Aug 2010 B2
7787958 Stevenson Aug 2010 B2
7794476 Wisnewski Sep 2010 B2
7794499 Navarro et al. Sep 2010 B2
7806935 Navarro et al. Oct 2010 B2
7811328 Molz, IV et al. Oct 2010 B2
7822465 Carls et al. Oct 2010 B2
7835779 Anderson et al. Nov 2010 B2
7837691 Cordes et al. Nov 2010 B2
7862586 Malek Jan 2011 B2
7867235 Fell et al. Jan 2011 B2
7875033 Richter et al. Jan 2011 B2
7878988 Bush et al. Feb 2011 B2
7901381 Birk et al. Mar 2011 B2
7909852 Boomer et al. Mar 2011 B2
7918844 Byrum et al. Apr 2011 B2
7935116 Michelson May 2011 B2
7938831 Leroux et al. May 2011 B2
7938841 Sharkawy et al. May 2011 B2
7955357 Kiester Jun 2011 B2
7981144 Geist et al. Jul 2011 B2
7985256 Grotz et al. Jul 2011 B2
7988709 Clark et al. Aug 2011 B2
7993269 Donofrio et al. Aug 2011 B2
8002809 Baynham Aug 2011 B2
8011308 Picchio Sep 2011 B2
8016859 Donofrio et al. Sep 2011 B2
8026729 Kroh et al. Sep 2011 B2
8034080 Malandain et al. Oct 2011 B2
8043299 Conway Oct 2011 B2
8043338 Dant Oct 2011 B2
8057473 Orsak et al. Nov 2011 B2
8057513 Kohm et al. Nov 2011 B2
8066650 Lee et al. Nov 2011 B2
8070695 Gupta et al. Dec 2011 B2
8075601 Young Dec 2011 B2
8083741 Morgan et al. Dec 2011 B2
8092499 Roth Jan 2012 B1
8095317 Ekseth et al. Jan 2012 B2
8105360 Connor Jan 2012 B1
8114158 Carl et al. Feb 2012 B2
8123805 Makower et al. Feb 2012 B2
8133280 Voellmicke et al. Mar 2012 B2
8147549 Metcalf, Jr. et al. Apr 2012 B2
8162897 Byrum Apr 2012 B2
8162979 Sachs et al. Apr 2012 B2
8177789 Magill et al. May 2012 B2
8197490 Pool et al. Jun 2012 B2
8206387 Michelson Jun 2012 B2
8211149 Justis Jul 2012 B2
8211151 Schwab et al. Jul 2012 B2
8216279 Bruneau et al. Jul 2012 B2
8221420 Keller Jul 2012 B2
8226690 Altarac et al. Jul 2012 B2
8236002 Fortin et al. Aug 2012 B2
8237451 Joy et al. Aug 2012 B2
8241331 Arnin Aug 2012 B2
8246630 Manzi et al. Aug 2012 B2
8252063 Stauch Aug 2012 B2
8267969 Altarac et al. Sep 2012 B2
8278941 Kroh et al. Oct 2012 B2
8282671 Connor Oct 2012 B2
8323290 Metzger et al. Dec 2012 B2
8343153 Duda et al. Jan 2013 B2
8343192 Kiester Jan 2013 B2
8357182 Seme Jan 2013 B2
8366628 Denker et al. Feb 2013 B2
8372078 Collazo Feb 2013 B2
8386018 Stauch et al. Feb 2013 B2
8388553 James et al. Mar 2013 B2
8394124 Biyani Mar 2013 B2
8403958 Schwab Mar 2013 B2
8414584 Brigido Apr 2013 B2
8419734 Walker et al. Apr 2013 B2
8425608 Dewey et al. Apr 2013 B2
8435268 Thompson et al. May 2013 B2
8439926 Bojarski et al. May 2013 B2
8444693 Reiley May 2013 B2
8469908 Asfora Jun 2013 B2
8470004 Reiley Jun 2013 B2
8486070 Morgan et al. Jul 2013 B2
8486076 Chavarria et al. Jul 2013 B2
8486147 De Villiers et al. Jul 2013 B2
8494805 Roche et al. Jul 2013 B2
8496662 Novak et al. Jul 2013 B2
8518062 Cole et al. Aug 2013 B2
8523866 Sidebotham et al. Sep 2013 B2
8529474 Gupta et al. Sep 2013 B2
8529606 Alamin et al. Sep 2013 B2
8529607 Alamin et al. Sep 2013 B2
8551092 Morgan et al. Oct 2013 B2
8556901 Anthony et al. Oct 2013 B2
8556911 Mehta et al. Oct 2013 B2
8556975 Ciupik et al. Oct 2013 B2
8562653 Alamin et al. Oct 2013 B2
8568457 Hunziker Oct 2013 B2
8570187 Janna et al. Oct 2013 B2
8617220 Skaggs Oct 2013 B2
8579979 Edie et al. Nov 2013 B2
8585595 Heilman Nov 2013 B2
8585740 Ross et al. Nov 2013 B1
8591549 Lange Nov 2013 B2
8591553 Eisermann et al. Nov 2013 B2
8613758 Linares Dec 2013 B2
8622936 Schenberger et al. Jan 2014 B2
8623036 Harrison et al. Jan 2014 B2
8632544 Haaja et al. Jan 2014 B2
8632548 Soubeiran Jan 2014 B2
8632563 Nagase et al. Jan 2014 B2
8636771 Butler et al. Jan 2014 B2
8636802 Serhan et al. Jan 2014 B2
8641719 Gephart et al. Feb 2014 B2
8641723 Connor Feb 2014 B2
8657856 Gephart et al. Feb 2014 B2
8663285 Dall et al. Mar 2014 B2
8663287 Butler et al. Mar 2014 B2
8668719 Alamin et al. Mar 2014 B2
8685093 Anderson et al. Apr 2014 B2
8690888 Stein et al. Apr 2014 B2
8709090 Makower et al. Apr 2014 B2
8721570 Gupta et al. May 2014 B2
8758347 Weiner et al. Jun 2014 B2
8758355 Fisher et al. Jun 2014 B2
8771272 LeCronier et al. Jul 2014 B2
8777877 Stein et al. Jul 2014 B2
8777947 Zahrly et al. Jul 2014 B2
8777995 McClintock et al. Jul 2014 B2
8784339 Stein et al. Jul 2014 B2
8790343 McClellan et al. Jul 2014 B2
8790409 Van den Heuvel et al. Jul 2014 B2
8828058 Elsebaie et al. Sep 2014 B2
8828087 Stone et al. Sep 2014 B2
8840651 Reiley Sep 2014 B2
8852236 Kiester Oct 2014 B2
8870881 Rezach et al. Oct 2014 B2
8870959 Arnin Oct 2014 B2
8896324 Kroh et al. Nov 2014 B2
8906091 Duda et al. Dec 2014 B2
8911448 Stein Dec 2014 B2
8915915 Harrison et al. Dec 2014 B2
8915917 Doherty et al. Dec 2014 B2
8920422 Homeier et al. Dec 2014 B2
8926674 Wolter et al. Jan 2015 B2
8945133 Stein et al. Feb 2015 B2
8945188 Rezach et al. Feb 2015 B2
8961521 Keefer et al. Feb 2015 B2
8961567 Hunziker Feb 2015 B2
8968402 Myers et al. Mar 2015 B2
8992527 Guichet Mar 2015 B2
9022917 Kasic et al. May 2015 B2
9044218 Young Jun 2015 B2
9060743 Munro et al. Jun 2015 B2
9060810 Kercher et al. Jun 2015 B2
9078703 Arnin Jul 2015 B2
9107580 Goguin et al. Aug 2015 B2
9278214 Young Mar 2016 B2
9320617 Abdou et al. Apr 2016 B2
9445720 Janna et al. Sep 2016 B2
9510785 Munro et al. Dec 2016 B2
RE46582 Morgan et al. Oct 2017 E
9795423 Deirmengian et al. Oct 2017 B2
9820869 Aryan Nov 2017 B2
9839374 Roche et al. Dec 2017 B2
10117580 Puryear et al. Nov 2018 B1
10123881 Moskowitz et al. Nov 2018 B2
10271832 O'Neil et al. Apr 2019 B2
10292831 Zellmer et al. May 2019 B2
10441210 Deirmengian et al. Oct 2019 B2
10524718 Young Jan 2020 B2
10595771 Deirmengian et al. Mar 2020 B2
10617880 Zellmer et al. Apr 2020 B2
10639167 Benson et al. May 2020 B2
10675069 Deirmengian et al. Jun 2020 B2
10702189 Droit et al. Jul 2020 B2
10765527 Chin et al. Sep 2020 B2
10940025 O'Neil et al. Mar 2021 B2
10952867 Moskowitz et al. Mar 2021 B2
11058549 Zellmer et al. Jul 2021 B2
11123197 Gross Sep 2021 B2
11298162 Benson et al. Apr 2022 B2
11304819 Chevalier Apr 2022 B2
20020049394 Roy et al. Apr 2002 A1
20020050112 Koch et al. May 2002 A1
20020072758 Reo et al. Jun 2002 A1
20020164905 Bryant Nov 2002 A1
20030040671 Somogyi et al. Feb 2003 A1
20030083746 Kuslich May 2003 A1
20030144669 Robinson Jul 2003 A1
20030220643 Ferree Nov 2003 A1
20030220644 Thelen et al. Nov 2003 A1
20040011137 Hnat et al. Jan 2004 A1
20040011365 Govari et al. Jan 2004 A1
20040019353 Freid et al. Jan 2004 A1
20040023623 Stauch et al. Feb 2004 A1
20040055610 Forsell Mar 2004 A1
20040073221 Biscup Apr 2004 A1
20040133219 Forsell Jul 2004 A1
20040138725 Forsell Jul 2004 A1
20040193266 Meyer Sep 2004 A1
20040243130 Biscup Dec 2004 A1
20050010301 Disilvestro et al. Jan 2005 A1
20050034705 McClendon Feb 2005 A1
20050049617 Chatlynne et al. Mar 2005 A1
20050065529 Liu et al. Mar 2005 A1
20050090823 Bartimus Apr 2005 A1
20050159754 Odrich Jul 2005 A1
20050234448 McCarthy Oct 2005 A1
20050234462 Hershberger Oct 2005 A1
20050246034 Soubeiran Nov 2005 A1
20050261779 Meyer Nov 2005 A1
20050272976 Tanaka et al. Dec 2005 A1
20060004459 Hazebrouck et al. Jan 2006 A1
20060009767 Kiester Jan 2006 A1
20060036259 Carl et al. Feb 2006 A1
20060036323 Carl et al. Feb 2006 A1
20060036324 Sachs et al. Feb 2006 A1
20060047282 Gordon Mar 2006 A1
20060052782 Morgan et al. Mar 2006 A1
20060058792 Hynes Mar 2006 A1
20060069447 DiSilvestro et al. Mar 2006 A1
20060074448 Harrison et al. Apr 2006 A1
20060079897 Harrison et al. Apr 2006 A1
20060136062 DiNello et al. Jun 2006 A1
20060142767 Green et al. Jun 2006 A1
20060155279 Ogilvie Jul 2006 A1
20060195087 Sacher et al. Aug 2006 A1
20060195088 Sacher et al. Aug 2006 A1
20060200134 Freid et al. Sep 2006 A1
20060204156 Takehara et al. Sep 2006 A1
20060235299 Martinelli Oct 2006 A1
20060235424 Vitale et al. Oct 2006 A1
20060241746 Shaoulian et al. Oct 2006 A1
20060241767 Doty Oct 2006 A1
20060247773 Stamp Nov 2006 A1
20060249914 Dulin Nov 2006 A1
20060271107 Harrison et al. Nov 2006 A1
20060282073 Simanovsky Dec 2006 A1
20060293683 Stauch Dec 2006 A1
20070010814 Stauch Jan 2007 A1
20070010887 Williams et al. Jan 2007 A1
20070021644 Woolson et al. Jan 2007 A1
20070031131 Griffitts Feb 2007 A1
20070043376 Leatherbury et al. Feb 2007 A1
20070050030 Kim Mar 2007 A1
20070118215 Moaddeb May 2007 A1
20070161984 Cresina et al. Jul 2007 A1
20070173837 Chan et al. Jul 2007 A1
20070179493 Kim Aug 2007 A1
20070185374 Kick et al. Aug 2007 A1
20070233098 Mastrorio et al. Oct 2007 A1
20070239159 Altarac et al. Oct 2007 A1
20070239161 Giger et al. Oct 2007 A1
20070255088 Jacobson et al. Nov 2007 A1
20070270803 Giger et al. Nov 2007 A1
20070276368 Trieu et al. Nov 2007 A1
20070276369 Allard et al. Nov 2007 A1
20070276373 Malandain Nov 2007 A1
20070276378 Harrison et al. Nov 2007 A1
20070276493 Malandain et al. Nov 2007 A1
20070288024 Gollogly Dec 2007 A1
20070288183 Bulkes et al. Dec 2007 A1
20080009792 Henniges et al. Jan 2008 A1
20080015577 Loeb Jan 2008 A1
20080021454 Chao et al. Jan 2008 A1
20080021455 Chao et al. Jan 2008 A1
20080021456 Gupta et al. Jan 2008 A1
20080027436 Cournoyer et al. Jan 2008 A1
20080033431 Jung et al. Feb 2008 A1
20080033436 Song et al. Feb 2008 A1
20080051784 Gollogly Feb 2008 A1
20080082118 Edidin et al. Apr 2008 A1
20080086128 Lewis Apr 2008 A1
20080097487 Pool et al. Apr 2008 A1
20080097496 Chang et al. Apr 2008 A1
20080108995 Conway et al. May 2008 A1
20080133016 Heinz Jun 2008 A1
20080147125 Colleran et al. Jun 2008 A1
20080154265 Duda et al. Jun 2008 A1
20080161933 Grotz et al. Jul 2008 A1
20080167685 Allard et al. Jul 2008 A1
20080172063 Taylor Jul 2008 A1
20080177319 Schwab Jul 2008 A1
20080177326 Thompson Jul 2008 A1
20080190237 Radinger et al. Aug 2008 A1
20080208516 James Aug 2008 A1
20080228186 Gall et al. Sep 2008 A1
20080255615 Vittur et al. Oct 2008 A1
20080272928 Shuster Nov 2008 A1
20080275557 Makower et al. Nov 2008 A1
20090030462 Buttermann Jan 2009 A1
20090076597 Dahlgren et al. Mar 2009 A1
20090082815 Zylber et al. Mar 2009 A1
20090088803 Justis et al. Apr 2009 A1
20090093820 Trieu et al. Apr 2009 A1
20090093890 Gelbart Apr 2009 A1
20090098092 Meredith Apr 2009 A1
20090112263 Pool et al. Apr 2009 A1
20090163780 Tieu Jun 2009 A1
20090171356 Klett Jul 2009 A1
20090192514 Feinberg et al. Jul 2009 A1
20090198144 Phillips et al. Aug 2009 A1
20090216113 Meier et al. Aug 2009 A1
20090222050 Wolter et al. Sep 2009 A1
20090275984 Kim et al. Nov 2009 A1
20100004654 Schmitz et al. Jan 2010 A1
20100057127 McGuire et al. Mar 2010 A1
20100094306 Chang et al. Apr 2010 A1
20100100185 Trieu et al. Apr 2010 A1
20100106192 Barry Apr 2010 A1
20100114322 Clifford et al. May 2010 A1
20100130941 Conlon et al. May 2010 A1
20100137872 Kam et al. Jun 2010 A1
20100145449 Makower et al. Jun 2010 A1
20100145462 Ainsworth et al. Jun 2010 A1
20100168751 Anderson et al. Jul 2010 A1
20100249533 Pierce et al. Sep 2010 A1
20100249782 Durham Sep 2010 A1
20100256626 Muller et al. Oct 2010 A1
20100262239 Boyden et al. Oct 2010 A1
20100268119 Morrison Oct 2010 A1
20100318129 Seme et al. Dec 2010 A1
20100331883 Schmitz et al. Dec 2010 A1
20110004076 Janna et al. Jan 2011 A1
20110057756 Marinescu et al. Mar 2011 A1
20110066188 Seme et al. Mar 2011 A1
20110098748 Jangra Apr 2011 A1
20110152725 Demir et al. Jun 2011 A1
20110196435 Forsell Aug 2011 A1
20110202138 Shenoy et al. Aug 2011 A1
20110238126 Soubeiran Sep 2011 A1
20110257655 Copf, Jr. Oct 2011 A1
20110284014 Cadeddu et al. Nov 2011 A1
20110295159 Shachar et al. Dec 2011 A1
20120019341 Gabay et al. Jan 2012 A1
20120019342 Gabay et al. Jan 2012 A1
20120053633 Stauch Mar 2012 A1
20120065497 Brown et al. Mar 2012 A1
20120088953 King Apr 2012 A1
20120109207 Trieu May 2012 A1
20120116535 Ratron et al. May 2012 A1
20120158061 Koch et al. Jun 2012 A1
20120172883 Sayago Jul 2012 A1
20120179215 Soubeiran Jul 2012 A1
20120221106 Makower et al. Aug 2012 A1
20120245636 Dall Sep 2012 A1
20120253345 Wixted Oct 2012 A1
20120271353 Barry Oct 2012 A1
20120289865 Lambrecht et al. Nov 2012 A1
20120296234 Wilhelm et al. Nov 2012 A1
20120329882 Messersmith et al. Dec 2012 A1
20130013066 Landry et al. Jan 2013 A1
20130072932 Stauch Mar 2013 A1
20130079678 Stein et al. Mar 2013 A1
20130123847 Anderson et al. May 2013 A1
20130138017 Jundt et al. May 2013 A1
20130138154 Reiley May 2013 A1
20130150863 Baumgartner Jun 2013 A1
20130150889 Fening et al. Jun 2013 A1
20130150970 Thaiyananthan Jun 2013 A1
20130178903 Abdou Jul 2013 A1
20130211521 Shenoy et al. Aug 2013 A1
20130245692 Hayes et al. Sep 2013 A1
20130253344 Griswold et al. Sep 2013 A1
20130253587 Carls et al. Sep 2013 A1
20130261672 Horvath Oct 2013 A1
20130296863 Globerman et al. Nov 2013 A1
20130296864 Burley et al. Nov 2013 A1
20130296940 Northcutt et al. Nov 2013 A1
20130325006 Michelinie et al. Dec 2013 A1
20130325071 Niemiec et al. Dec 2013 A1
20140005788 Haaja et al. Jan 2014 A1
20140025172 Lucas et al. Jan 2014 A1
20140052134 Orisek Feb 2014 A1
20140058392 Mueckter et al. Feb 2014 A1
20140058450 Arlet Feb 2014 A1
20140066987 Hestad et al. Mar 2014 A1
20140088715 Ciupik Mar 2014 A1
20140128920 Kantelhardt May 2014 A1
20140163664 Goldsmith Jun 2014 A1
20140236234 Kroll et al. Aug 2014 A1
20140236311 Vicatos et al. Aug 2014 A1
20140257412 Patty et al. Sep 2014 A1
20140277446 Clifford et al. Sep 2014 A1
20140296918 Fening et al. Oct 2014 A1
20140303538 Baym et al. Oct 2014 A1
20140303539 Baym et al. Oct 2014 A1
20140358150 Kaufman et al. Dec 2014 A1
20150105782 D'Lima et al. Apr 2015 A1
20150105824 Moskowitz et al. Apr 2015 A1
20160113683 Cheng Apr 2016 A1
20160270927 Zellmer et al. Sep 2016 A1
20160367297 Nill Dec 2016 A1
20170007420 Stevenson et al. Jan 2017 A1
20170079555 Munro et al. Mar 2017 A1
20170172624 Brunner Jun 2017 A1
20170196508 Hunter Jul 2017 A1
20170231559 Cuevas et al. Aug 2017 A1
20180055444 Windolf Mar 2018 A1
20180153709 Hunter Jun 2018 A1
20180192939 Roth et al. Jul 2018 A1
20180318579 Puryear et al. Nov 2018 A1
20190008386 Puryear et al. Jan 2019 A1
20190009083 Webster et al. Jan 2019 A1
20190150835 Bae May 2019 A1
20190156482 Deitz et al. May 2019 A1
20190224022 Zellmer et al. Jul 2019 A1
20190365541 Friis et al. Dec 2019 A1
20200022733 Benson et al. Jan 2020 A1
20200022772 Benson et al. Jan 2020 A1
20200069247 Hunter Mar 2020 A1
20200107940 Murphy et al. Apr 2020 A1
20200108252 Zellmer et al. Apr 2020 A1
20200187849 Deirmengian et al. Jun 2020 A1
20200253588 Bae Aug 2020 A1
20200253651 Deirmengian et al. Aug 2020 A1
20200297513 Zellmer et al. Sep 2020 A1
20200352723 Jimenez et al. Nov 2020 A1
20210052394 Chin et al. Feb 2021 A1
20210077216 Ledet et al. Mar 2021 A1
20210101002 Saigal et al. Apr 2021 A1
20210128919 Zellmer et al. May 2021 A1
20210161682 O'Neil et al. Jun 2021 A1
20210205625 Friis et al. Jul 2021 A1
20210243899 Harris et al. Aug 2021 A1
20210315708 Moskowitz et al. Oct 2021 A1
Foreign Referenced Citations (32)
Number Date Country
1697630 Nov 2005 CN
101040807 Sep 2007 CN
1541262 Jun 1969 DE
8515687 Dec 1985 DE
19626230 Jan 1998 DE
19745654 Apr 1999 DE
102005045070 Apr 2007 DE
0663184 Jul 1995 EP
1240873 Sep 2002 EP
1905388 Apr 2008 EP
2901991 Dec 2007 FR
2900563 Aug 2008 FR
2892617 Sep 2008 FR
2916622 Sep 2009 FR
2961386 Dec 2011 FR
H0956736 Mar 1997 JP
2002500063 Jan 2002 JP
WO1998044858 Oct 1998 WO
WO1999051160 Oct 1999 WO
WO2001024697 Apr 2001 WO
WO2001045485 Jun 2001 WO
WO2001045487 Jun 2001 WO
WO2001067973 Sep 2001 WO
WO2001078614 Oct 2001 WO
2006010933 Feb 2006 WO
WO2007013059 Feb 2007 WO
WO2007015239 Feb 2007 WO
WO2011116158 Sep 2011 WO
WO2013119528 Aug 2013 WO
WO2014040013 Mar 2014 WO
2016172806 Nov 2016 WO
2020055874 Mar 2020 WO
Non-Patent Literature Citations (102)
Entry
Abe et al., “Experimental external fixation combined with percutaneous discectomy in the management of scoliosis.”, SPINE, 1999, pp. 646-653, 24, No. 7.
Ahlbom et al., “Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz). International Commission on Non-Ionizing Radiation Protection.”, Health Physics, 1998, pp. 494-522, 74, No. 4.
Amer et al., “Evaluation of treatment of late-onset tibia vara using gradual angulation translation high tibial osteotomy”, ACTA Orthopaedica Belgica, 2010, pp. 360-366, 76, No. 3.
Angrisani et al., “Lap-Band® Rapid Port™M System: Preliminary results in 21 patients”, Obesity Surgery, 2005, p. 936, 15, No. 7.
Baumgart et al., “A fully implantable, programmable distraction nail (Fitbone)—new perspectives for corrective and reconstructive limb surgery.”, Practice of Intramedullary Locked Nails, 2006, pp. 189-198.
Baumgart et al., “The bioexpandable prosthesis: A new perspective after resection of malignant bone tumors in children.”, J Pediatr Hematol Oncol, 2005, pp. 452-455, 27, No. 8.
Bodó et al., “Development of a tension-adjustable implant for anterior cruciate ligament reconstruction.”, Eklem Hastaliklari ve Cerrahisi—Joint Diseases and Related Surgery, 2008, pp. 27-32, 19, No. 1.
Boudjemline et al., “Off-label use of an adjustable gastric banding system for pulmonary artery banding.”, The Journal of Thoracic and Cardiovascular Surgery, 2006, pp. 1130-1135, 131, No. 5.
Brown et al., “Single port surgery and the Dundee Endocone.”, SAGES Annual Scientific Sessions: Emerging Technology Poster Abstracts, 2007, ETP007, pp. 323-324.
Buchowski et al., “Temporary internal distraction as an aid to correction of severe scoliosis”, J Bone Joint Surg Am, 2006, pp. 2035-2041, 88-A, No. 9.
Burghardt et al., “Mechanical failure of the Intramedullary Skeletal Kinetic Distractor in limb lengthening.”, J Bone Joint Surg Br, 2011, pp. 639-643, 93-B, No. 5.
Burke, “Design of a minimally invasive non fusion device for the surgical management of scoliosis in the skeletally immature”, Studies in Health Technology and Informatics, 2006, pp. 378-384, 123.
Carter et al., “A cumulative damage model for bone fracture.”, Journal of Orthopaedic Research, 1985, pp. 84-90, 3, No. 1.
Chapman et al., “Laparoscopic adjustable gastric banding in the treatment of obesity: A systematic literature review.”, Surgery, 2004, pp. 326-351, 135, No. 3.
Cole et al., “Operative technique intramedullary skeletal kinetic distractor: Tibial surgical technique.”, Orthofix, 2005.
Cole et al., “The intramedullary skeletal kinetic distractor (ISKD): first clinical results of a new intramedullary nail for lengthening of the femur and tibia.”, Injury, 2001, pp. S-D-129-S-D-139, 32.
Dailey et al., “A novel intramedullary nail for micromotion stimulation of tibial fractures.”, Clinical Biomechanics, 2012, pp. 182-188, 27, No. 2.
Daniels et al., “A new method for continuous intraoperative measurement of Harrington rod loading patterns.”, Annals of Biomedical Engineering, 1984, pp. 233-246, 12, No. 3.
De Giorgi et al., “Cotrel-Dubousset instrumentation for the treatment of severe scoliosis.”, European Spine Journal, 1999, pp. 8-15, No. 1.
Dorsey et al., “The stability of three commercially available implants used in medial opening wedge high tibial osteotomy.”, Journal of Knee Surgery, 2006, pp. 95-98, 19, No. 2.
Edeland et al., “Instrumentation for distraction by limited surgery in scoliosis treatment.”, Journal of Biomedical Engineering, 1981, pp. 143-146, 3, No. 2.
Elsebaie, “Single growing rods (Review of 21 cases). Changing the foundations: Does it affect the results?”, Journal of Child Orthop, 2007, 1:258.
Ember et al., “Distraction forces required during growth rod lengthening.”, J of Bone Joint Surg BR, 2006, p. 229, 88-B, No. Suppl. II.
European Patent Office, “Observations by a third party under Article 115 EPC in EP08805612 by Soubeiran.”, 2010.
Fabry et al., “A technique for prevention of port complications after laparoscopic adjustable silicone gastric banding.”, Obesity Surgery, 2002, pp. 285-288, 12, No. 2.
Fried et al., “In vivo measurements of different gastric band pressures towards the gastric wall at the stoma region.”, Obesity Surgery, 2004, p. 914, 14, No. 7.
Gao et al., CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis, American Journal of Human Genetics, 2007, pp. 957-965, 80.
Gebhart et al., “Early clinical experience with a custom made growing endoprosthesis in children with malignant bone tumors of the lower extremity actioned by an external permanent magnet; The Phenix M. system”, International Society of Limb Salvage 14th International Symposium on Limb Salvage. Sep. 3, 2007, Hamburg, Germany. (2 pages).
Gillespie et al. “Harrington instrumentation without fusion.”, J Bone Joint Surg Br, 1981, p. 461, 63-B, No. 3.
Goodship et al., “Strain rate and timing of stimulation in mechanical modulation of fracture healing.”, Clinical Orthopaedics and Related Research, 1998, pp. S105-S115, No. 355S.
Grass et al., “Intermittent distracting rod for correction of high neurologic risk congenital scoliosis.”, SPINE, 1997, pp. 1922-1927, 22, No. 16.
Gray, “Gray's anatomy of the human body.”, http://education.yahoo.com/reference/gray/subjects/subject/128, published Jul. 1, 2007.
Grimer et al. “Non-invasive extendable endoprostheses for children—Expensive but worth it!”, International Society of Limb Salvage 14th International Symposium on Limb Salvage, 2007.
Grünert, “The development of a totally implantable electronic sphincter.” (translated from the German “Die Entwicklung eines total implantierbaren elektronischen Sphincters”), Langenbecks Archiv fur Chirurgie, 1969, pp. 1170-1174, 325.
Guichet et al. “Gradual femoral lengthening with the Albizzia intramedullary nail”, J Bone Joint Surg Am, 2003, pp. 838-848, 85-A, No. 5.
Gupta et al., “Non-invasive distal femoral expandable endoprosthesis for limb-salvage surgery in paediatric tumours.”, J Bone Joint Surg Br, 2006, pp. 649-654, 88-B, No. 5.
Hankemeier et al., “Limb lengthening with the Intramedullary Skeletal Kinetic Distractor (ISKD).”, Oper Orthop Traumatol, 2005, pp. 79-101, 17, No. 1.
Harrington, “Treatment of scoliosis. Correction and internal fixation by spine instrumentation.”, J Bone Joint Surg Am, 1962, pp. 591-610, 44-A, No. 4.
Hennig et al., “The safety and efficacy of a new adjustable plate used for proximal tibial opening wedge osteotomy in the treatment of unicompartmental knee osteoarthrosis.”, Journal of Knee Surgery, 2007, pp. 6-14, 20, No. 1.
Hofmeister et al., “Callus distraction with the Albizzia nail.”, Practice of Intramedullary Locked Nails, 2006, pp. 211-215.
Horbach et al., “First experiences with the routine use of the Rapid Port™ system with the Lap-Band®.”, Obesity Surgery, 2006, p. 418, 16, No. 4.
Hyodo et al., “Bone transport using intramedullary fixation and a single flexible traction cable.”, Clinical Orthopaedics and Related Research, 1996, pp. 256-268, 325.
International Commission on Non-Ionizing Radiation Protection, “Guidelines on limits of exposure to static magnetic fields.” Health Physics, 2009, pp. 504-514, 96, No. 4.
INVIS®/Lamello Catalog, 2006, Article No. 68906A001 GB.
Kasliwal et al., “Management of high-grade spondylolisthesis.”, Neurosurgery Clinics of North America, 2013, pp. 275-291, 24, No. 2.
Kenawey et al., “Leg lengthening using intramedullay skeletal kinetic distractor: Results of 57 consecutive applications.”, Injury, 2011, pp. 150-155, 42, No. 2.
Kent et al., “Assessment and correction of femoral malrotation following intramedullary nailing of the femur.”, Acta Orthop Belg, 2010, pp. 580-584, 76, No. 5.
Klemme et al., “Spinal instrumentation without fusion for progressive scoliosis in young children”, Journal of Pediatric Orthopaedics. 1997, pp. 734-742, 17, No. 6.
Korenkov et al., “Port function after laparoscopic adjustable gastric banding for morbid obesity.”, Surgical Endoscopy, 2003, pp. 1068-1071, 17, No. 7.
Krieg et al., “Leg lengthening with a motorized nail in adolescents.”, Clinical Orthopaedics and Related Research, 2008, pp. 189-197, 466, No. 1.
Kucukkaya et al., “The new intramedullary cable bone transport technique.”, Journal of Orthopaedic Trauma, 2009, pp. 531-536, 23, No. 7.
Lechner et al., “In vivo band manometry: A new method in band adjustment”, Obesity Surgery, 2005, p. 935, 15, No. 7.
Lechner et al., “Intra-band manometry for band adjustments: The basics”, Obesity Surgery, 2006, pp. 417-418, 16, No. 4.
Li et al., “Bone transport over an intramedullary nail: A case report with histologic examination of the regenerated segment.”, Injury, 1999, pp. 525-534, 30, No. 8.
Lonner, “Emerging minimally invasive technologies for the management of scoliosis.”, Orthopedic Clinics of North America, 2007, pp. 431-440, 38, No. 3.
Matthews et al., “Magnetically adjustable intraocular lens.”, Journal of Cataract and Refractive Surgery, 2003, pp. 2211-2216, 29, No. 11.
Micromotion, “Micro Drive Engineering. General catalogue.”, 2009, pp. 14-24.
Mineiro et al., “Subcutaneous rodding for progressive spinal curvatures: Early results.”, Journal of Pediatric Orthopaedics, 2002, pp. 290-295, 22, No. 3.
Moe et al., “Harrington instrumentation without fusion plus external orthotic support for the treatment of difficult curvature problems in young children.”, Clinical Orthopaedics and Related Research, 1984, pp. 35-45, 185.
Montague et al., “Magnetic gear dynamics for servo control.”, Melecon 2010—2010 15th IEEE Mediterranean Electrotechnical Conference, Valletta, 2010, pp. 1192-1197.
Montague et al., “Servo control of magnetic gears.”, IEEE/ASME Transactions on Mechatronics, 2012, pp. 269-278, 17, No. 2.
Nachemson et al., “Intravital wireless telemetry of axial forces in Harrington distraction rods in patients with idiopathic scoliosis.”, The Journal of Bone and Joint Surgery, 1971, pp. 445-465, 53, No. 3.
Nachlas et al., “The cure of experimental scoliosis by directed growth control.”, The Journal of Bone and Joint Surgery, 1951, pp. 24-34, 33-A, No. 1.
Newton et al., “Fusionless scoliosis correction by anterolateral tethering . . . can it work ?. ”, 39th Annual Scoliosis Research Society Meeting, 2004.
Oh et al., “Bone transport over an intramedullary nail for reconstruction of long bone defects in tibia.”, Archives of Orthopaedic and Trauma Surgery, 2008, pp. 801-808, 128, No. 8.
Ozcivici et al., “Mechanical signals as anabolic agents in bone.”, Nature Reviews Rheumatology, 2010, pp. 50-59, 6, No. 1.
Piorkowski et al., Preventing Port Site Inversion in Laparoscopic Adjustable Gastric Banding, Surgery for Obesity and Related Diseases, 2007, 3(2), pp. 159-162, Elsevier; New York, U.S.A.
Prontes, “Longest bone in body.”, eHow.com, 2012.
Rathjen et al., “Clinical and radiographic results after implant removal in idiopathic scoliosis.”, SPINE, 2007, pp. 2184-2188, 32, No. 20.
Ren et al., “Laparoscopic adjustable gastric banding: Surgical technique”, Journal of Laparoendoscopic & Advanced Surgical Techniques, 2003, pp. 257-263, 13, No. 4.
Reyes-Sanchez et al., “External fixation for dynamic correction of severe scoliosis”, The Spine Journal, 2005, pp. 418-426, 5, No. 4.
Rinsky et al., “Segmental instrumentation without fusion in children with progressive scoliosis.”, Journal of Pediatric Orthopedics, 1985, pp. 687-690, 5, No. 6.
Rode et al., “A simple way to adjust bands under radiologic control”, Obesity Surgery, 2006, p. 418, 16, No. 4.
Schmerling et al., “Using the shape recovery of nitinol in the Harrington rod treatment of scoliosis.”, Journal of Biomedical Materials Research, 1976, pp. 879-892, 10, No. 6.
Scott et al., “Transgastric, transcolonic and transvaginal cholecystectomy using magnetically anchored instruments.”, SAGES Annual Scientific Sessions, Poster Abstracts, Apr. 18-22, 2007, P511, p. 306.
Sharke, “The machinery of life”, Mechanical Engineering Magazine, Feb. 2004, Printed from Internet site Oct. 24, 2007 http://www.memagazine.org/contents/current/features/moflife/moflife.html.
Shiha et al., “Ilizarov gradual correction of genu varum deformity in adults.”, Acta Orthop Belg, 2009, pp. 784-791, 75, No. 6.
Simpson et al., “Femoral lengthening with the intramedullary skeletal kinetic distractor.”, Journal of Bone and Joint Surgery, 2009, pp. 955-961, 91-B, No. 7.
Smith, “The use of growth-sparing instrumentation in pediatric spinal deformity.”, Orthopedic Clinics of North America, 2007, pp. 547-552, 38, No. 4.
Soubeiran et al. “The Phenix M System, a fully implanted non-invasive lengthening device externally controllable through the skin with a palm size permanent magnet. Applications in limb salvage.” International Society of Limb Salvage 14th International Symposium on Limb Salvage, Sep. 13, 2007, Hamburg, Germany. (2 pages).
Soubeiran et al., “The Phenix M System. A fully implanted lengthening device externally controllable through the skin with a palm size permanent magnet; Applications to pediatric orthopaedics”, 6th European Research Conference in Pediatric Orthopaedics, Oct. 6, 2006, Toulouse, France (7 pages).
Stokes et al., “Reducing radiation exposure in early-onset scoliosis surgery patients: Novel use of ultrasonography to measure lengthening in magnetically-controlled growing rods. Prospective validation study and assessment of clinical algorithm”, 20th International Meeting on Advanced Spine Techniques, Jul. 11, 2013. Vancouver, Canada. Scoliosis Research Society.
Sun et al., “Masticatory mechanics of a mandibular distraction osteogenesis site: Interfragmentary micromovement.”, Bone, 2007, pp. 188-196, 41, No. 2.
Synthes Spine, “VEPTR II. Vertical Expandable Prosthetic Titanium Rib II: Technique Guide.”, 2008, 40 pgs.
Synthes Spine, “VEPTR Vertical Expandable Prosthetic Titanium Rib, Patient Guide.”, 2005, 26 pgs.
Takaso et al., “New remote-controlled growing-rod spinal instrumentation possibly applicable for scoliosis in young children.”, Journal of Orthopaedic Science, 1998, pp. 336-340, 3, No. 6.
Teli et al., “Measurement of forces generated during distraction of growing rods.”, Journal of Children's Orthopaedics, 2007, pp. 257-258, 1, No. 4.
Tello, “Harrington instrumentation without arthrodesis and consecutive distraction program for young children with severe spinal deformities: Experience and technical details.”, The Orthopedic Clinics of North America, 1994, pp. 333-351, 25, No. 2.
Thaller et al., “Limb lengthening with fully implantable magnetically actuated mechanical nails (PHENIX®)—Preliminary results.”, Injury, 2014 (E-published Oct. 28, 2013), pp. S60-S65, 45.
Thompson et al., “Early onset scoliosis: Future directions”, 2007, J Bone Joint Surg Am, pp. 163-166, 89-A, Suppl 1.
Thompson et al., “Growing rod techniques in early-onset scoliosis”, Journal of Pediatric Orthopedics, 2007, pp. 354-361, 27, No. 3.
Thonse et al., “Limb lengthening with a fully implantable, telescopic, intramedullary nail.”, Operative Techniques in Orthopedics, 2005, pp. 355-362, 15, No. 4.
Trias et al., “Dynamic loads experienced in correction of idiopathic scoliosis using two types of Harrington rods.”, SPINE, 1979, pp. 228-235, 4, No. 3.
Verkerke et al., “An extendable modular endoprosthetic system for bone tumor management in the leg”, Journal of Biomedical Engineering, 1990, pp. 91-96, 12, No. 2.
Verkerke et al., “Design of a lengthening element for a modular femur endoprosthetic system”, Proceedings of the Institution of Mechanical Engineers Part H: Journal of Engineering in Medicine, 1989, pp. 97-102, 203, No. 2.
Verkerke et al., “Development and test of an extendable endoprosthesis for bone reconstruction in the leg.”, The International Journal of Artificial Organs, 1994, pp. 155-162, 17, No. 3.
Weiner et al., “Initial clinical experience with telemetrically adjustable gastric banding”, Surgical Technology International, 2005, pp. 63-69, 15.
Wenger, “Spine jack operation in the correction of scoliotic deformity: A direct intrathoracic attack to straighten the laterally bent spine: Preliminary report”, Arch Surg, 1961, pp. 123-132 (901-910), 83, No. 6.
White, III et al., “The clinical biomechanics of scoliosis.”, Clinical Orthopaedics and Related Research, 1976, pp. 100-112, 118.
Yonnet, “A new type of permanent magnet coupling.”, IEEE Transactions on Magnetics, 1981, pp. 2991-2993, 17, No. 6.
Yonnet, “Passive magnetic bearings with permanent magnets.”, IEEE Transactions on Magnetics, 1978, pp. 803-805, 14, No. 5.
Zheng et al., “Force and torque characteristics for magnetically driven blood pump.”, Journal of Magnetism and Magnetic Materials, 2002, pp. 292-302, 241, No. 2.
Related Publications (1)
Number Date Country
20220265327 A1 Aug 2022 US
Provisional Applications (1)
Number Date Country
63152562 Feb 2021 US